text_a,span_text_a,text_b,span_text_b,normalized_vertical_gap,indentation_change,same_alignment,is_centered_A,is_centered_B,font_size_a,font_size_b,font_size_diff,same_font,is_bold_A,is_bold_B,is_italic_A,is_italic_B,is_monospace_A,is_monospace_B,same_bold,same_italic,same_monospace,line_a_ends_punctuation,line_b_starts_lowercase,is_linea_in_rectangle,is_lineb_in_rectangle,both_in_table,neither_in_table,is_linea_hashed,is_lineb_hashed,both_hashed,neither_hashed,page_number_a,page_number_b,label
Recent Developments in GNNs for Drug Discovery,Recent Developments in GNNs for Drug Discovery,"Zhengyu Fang 1, Xiaoge Zhang 1, Anyin Zhao 1, Xiao Li 1,2,3,4, Huiyuan Chen 1, and Jing","Zhengyu Fang1, Xiaoge Zhang1, Anyin Zhao1, Xiao Li1,2,3,4, Huiyuan Chen1, and Jing",5.24,-27.88,0,1,0,17.22,11.96,-5.26,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,1,0,0,0,1,1,0
"Zhengyu Fang 1, Xiaoge Zhang 1, Anyin Zhao 1, Xiao Li 1,2,3,4, Huiyuan Chen 1, and Jing","Zhengyu Fang1, Xiaoge Zhang1, Anyin Zhao1, Xiao Li1,2,3,4, Huiyuan Chen1, and Jing",Li *1,Li*1,1,195.81,0,0,1,11.96,11.96,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,1,1,1
Li *1,Li*1,"1 Department of Computer and Data Sciences, Case Western Reserve University","1Department of Computer and Data Sciences, Case Western Reserve University",3.55,-180.55,0,1,0,11.96,7.97,-3.99,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,1,1,0
"1 Department of Computer and Data Sciences, Case Western Reserve University","1Department of Computer and Data Sciences, Case Western Reserve University","2 Department of Biochemistry, Case Western Reserve University","2Department of Biochemistry, Case Western Reserve University",2.09,37.4,0,0,0,7.97,7.97,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,1,1,1
"2 Department of Biochemistry, Case Western Reserve University","2Department of Biochemistry, Case Western Reserve University","3 Center for RNA Science and Therapeutics, Case Western Reserve University","3Center for RNA Science and Therapeutics, Case Western Reserve University",2.09,-32.87,0,0,0,7.97,7.97,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,1,1,1
"3 Center for RNA Science and Therapeutics, Case Western Reserve University","3Center for RNA Science and Therapeutics, Case Western Reserve University","4 Department of Biomedical Engineering, Case Western Reserve University","4Department of Biomedical Engineering, Case Western Reserve University",2.09,6.42,0,0,0,7.97,7.97,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,1,1,1
"4 Department of Biomedical Engineering, Case Western Reserve University","4Department of Biomedical Engineering, Case Western Reserve University",Abstract,Abstract,16.11,160.86,0,0,1,7.97,9.96,1.99,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,1,1,0
Abstract,Abstract,"In this paper, we review recent developments and the role of Graph Neural Networks GNNs","In this paper, we review recent developments and the role of Graph Neural Networks (GNNs)",2.48,-170.76,0,1,1,9.96,9.96,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,1,1,0
"In this paper, we review recent developments and the role of Graph Neural Networks GNNs","In this paper, we review recent developments and the role of Graph Neural Networks (GNNs)","in computational drug discovery, including molecule generation, molecular property prediction,","in computational drug discovery, including molecule generation, molecular property prediction,",0.94,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
"in computational drug discovery, including molecule generation, molecular property prediction,","in computational drug discovery, including molecule generation, molecular property prediction,",and drug-drug interaction prediction. By summarizing the most recent developments in this,and drug-drug interaction prediction. By summarizing the most recent developments in this,0.94,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
and drug-drug interaction prediction. By summarizing the most recent developments in this,and drug-drug interaction prediction. By summarizing the most recent developments in this,"area, we underscore the capabilities of GNNs to comprehend intricate molecular patterns, while","area, we underscore the capabilities of GNNs to comprehend intricate molecular patterns, while",0.94,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
"area, we underscore the capabilities of GNNs to comprehend intricate molecular patterns, while","area, we underscore the capabilities of GNNs to comprehend intricate molecular patterns, while","exploring both their current and prospective applications. We initiate our discussion by examining various molecular representations, followed by detailed discussions and categorization of","ining various molecular representations, followed by detailed discussions and categorization of",4.6,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
"exploring both their current and prospective applications. We initiate our discussion by examining various molecular representations, followed by detailed discussions and categorization of","ining various molecular representations, followed by detailed discussions and categorization of",existing GNN models based on their input types and downstream application tasks. We also,existing GNN models based on their input types and downstream application tasks. We also,0.94,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
existing GNN models based on their input types and downstream application tasks. We also,existing GNN models based on their input types and downstream application tasks. We also,collect a list of commonly used benchmark datasets for a variety of applications. We conclude,collect a list of commonly used benchmark datasets for a variety of applications. We conclude,0.94,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
collect a list of commonly used benchmark datasets for a variety of applications. We conclude,collect a list of commonly used benchmark datasets for a variety of applications. We conclude,the paper with brief discussions and summarize common trends in this important research area.,the paper with brief discussions and summarize common trends in this important research area.,0.94,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
the paper with brief discussions and summarize common trends in this important research area.,the paper with brief discussions and summarize common trends in this important research area.,"Keywords: Drug Discovery, Graph Neural Networks, Machine Learning","Keywords: Drug Discovery, Graph Neural Networks, Machine Learning",7.01,-24.91,0,1,0,9.96,9.96,0,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,1,1,0
"Keywords: Drug Discovery, Graph Neural Networks, Machine Learning","Keywords: Drug Discovery, Graph Neural Networks, Machine Learning",1 Introduction,Introduction,6.64,21.52,0,0,0,9.96,14.35,4.38,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,1,0,0,1,1,0
1 Introduction,Introduction,"It is well known that traditional drug discovery is costly, time-consuming, and with high failure rates 1.","It is well known that traditional drug discovery is costly, time-consuming, and with high failure rates [1].",3.84,-21.52,0,0,1,14.35,9.96,-4.38,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,1,1,0
"It is well known that traditional drug discovery is costly, time-consuming, and with high failure rates 1.","It is well known that traditional drug discovery is costly, time-consuming, and with high failure rates [1].","To streamline the process of drug discovery and mitigate resource-intensive laboratory work, significant","To streamline the process of drug discovery and mitigate resource-intensive laboratory work, significant",0.94,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,1,1,1
"To streamline the process of drug discovery and mitigate resource-intensive laboratory work, significant","To streamline the process of drug discovery and mitigate resource-intensive laboratory work, significant",research has been dedicated to the development of computational methods. Existing literature provides,research has been dedicated to the development of computational methods. Existing literature provides,0.94,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
research has been dedicated to the development of computational methods. Existing literature provides,research has been dedicated to the development of computational methods. Existing literature provides,"some comprehensive reviews on deep learning approaches in drug discovery 2, 3, 4, 5. In this review,","some comprehensive reviews on deep learning approaches in drug discovery [2, 3, 4, 5]. In this review,",0.94,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
"some comprehensive reviews on deep learning approaches in drug discovery 2, 3, 4, 5. In this review,","some comprehensive reviews on deep learning approaches in drug discovery [2, 3, 4, 5]. In this review,",we focus on the development and applications of Graph Neural Networks GNNs on three related areas of,we focus on the development and applications of Graph Neural Networks (GNNs) on three related areas of,0.94,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
we focus on the development and applications of Graph Neural Networks GNNs on three related areas of,we focus on the development and applications of Graph Neural Networks (GNNs) on three related areas of,"computational drug development, namely, Molecule Generation, Molecular Property Prediction, and Drug-","computational drug development, namely, Molecule Generation, Molecular Property Prediction, and Drug-",0.94,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
"computational drug development, namely, Molecule Generation, Molecular Property Prediction, and Drug-","computational drug development, namely, Molecule Generation, Molecular Property Prediction, and Drug-","Drug Interaction Prediction, which not only receive increasing attention but also show promising results.","Drug Interaction Prediction, which not only receive increasing attention but also show promising results.",0.96,0,1,0,0,9.96,9.96,0,0,0,0,0,1,0,0,1,0,1,0,0,0,0,0,1,0,0,0,1,1,1,1
"Drug Interaction Prediction, which not only receive increasing attention but also show promising results.","Drug Interaction Prediction, which not only receive increasing attention but also show promising results.",We will summarize some most recent developments in these research areas and focus on computational,We will summarize some most recent developments in these research areas and focus on computational,1.01,0,1,0,1,9.96,9.96,0,0,0,0,1,0,0,0,1,0,1,1,0,0,0,0,1,0,0,0,1,1,1,1
We will summarize some most recent developments in these research areas and focus on computational,We will summarize some most recent developments in these research areas and focus on computational,advances published since 2021.,advances published since 2021.,0.94,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,1,1,1
advances published since 2021.,advances published since 2021.,Corresponding author. jingli@case.edumailto:jingli@case.edu,*Corresponding author. jingli@case.edu,3.08,10.86,0,0,0,9.96,5.98,-3.98,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,1,1,1
1.1 Molecule Generation,Molecule Generation,An earlier step in developing a drug for a certain disease usually involves the search of enormous amount,An earlier step in developing a drug for a certain disease usually involves the search of enormous amount,3.09,-26.9,0,0,1,11.96,9.96,-1.99,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,2,2,0
An earlier step in developing a drug for a certain disease usually involves the search of enormous amount,An earlier step in developing a drug for a certain disease usually involves the search of enormous amount,of molecules to create a small subset of candidates for further laboratory testing. To reduce experimental,of molecules to create a small subset of candidates for further laboratory testing. To reduce experimental,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
of molecules to create a small subset of candidates for further laboratory testing. To reduce experimental,of molecules to create a small subset of candidates for further laboratory testing. To reduce experimental,"costs and to produce drug candidates more efficiently, many computational approaches have been developed to generate novel molecules 6, 7, 8, 9, 10. These approaches usually take some existing molecules","oped to generate novel molecules [6, 7, 8, 9, 10]. These approaches usually take some existing molecules",4.92,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"costs and to produce drug candidates more efficiently, many computational approaches have been developed to generate novel molecules 6, 7, 8, 9, 10. These approaches usually take some existing molecules","oped to generate novel molecules [6, 7, 8, 9, 10]. These approaches usually take some existing molecules",as inputs and generate valid but different molecules with high variety. Validity basically means that the,as inputs and generate valid but different molecules with high variety. Validity basically means that the,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
as inputs and generate valid but different molecules with high variety. Validity basically means that the,as inputs and generate valid but different molecules with high variety. Validity basically means that the,"generated molecules are possible to be synthesized. At the same time, high variety will ensure that the generated molecules span over a reasonably large molecular space in hope that some of them will have desired",erated molecules span over a reasonably large molecular space in hope that some of them will have desired,4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"generated molecules are possible to be synthesized. At the same time, high variety will ensure that the generated molecules span over a reasonably large molecular space in hope that some of them will have desired",erated molecules span over a reasonably large molecular space in hope that some of them will have desired,properties. Computational approaches are usually evaluated based on these two metrics.,properties. Computational approaches are usually evaluated based on these two metrics.,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
properties. Computational approaches are usually evaluated based on these two metrics.,properties. Computational approaches are usually evaluated based on these two metrics.,"Generally speaking, existing computational approaches can be characterized as two different types based","Generally speaking, existing computational approaches can be characterized as two different types based",1,14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,2,2,0
"Generally speaking, existing computational approaches can be characterized as two different types based","Generally speaking, existing computational approaches can be characterized as two different types based","on whether they can incorporate certain constrains. For some approaches 6, 7, any molecules can be","on whether they can incorporate certain constrains. For some approaches [6, 7], any molecules can be",1,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"on whether they can incorporate certain constrains. For some approaches 6, 7, any molecules can be","on whether they can incorporate certain constrains. For some approaches [6, 7], any molecules can be","generated, i.e., the generation of molecules has no constraints associated with them. For the second type","generated, i.e., the generation of molecules has no constraints associated with them. For the second type",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"generated, i.e., the generation of molecules has no constraints associated with them. For the second type","generated, i.e., the generation of molecules has no constraints associated with them. For the second type","of approaches 8, 9, 10, they only generate molecules satisfying certain constrains. For example, all the","of approaches [8, 9, 10], they only generate molecules satisfying certain constrains. For example, all the",1,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"of approaches 8, 9, 10, they only generate molecules satisfying certain constrains. For example, all the","of approaches [8, 9, 10], they only generate molecules satisfying certain constrains. For example, all the","generated molecules must include some fixed substructures such as ring structures. In other cases, the","generated molecules must include some fixed substructures such as ring structures. In other cases, the",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"generated molecules must include some fixed substructures such as ring structures. In other cases, the","generated molecules must include some fixed substructures such as ring structures. In other cases, the","constraints can be task specifics, for example, many approaches 11, 12, 13, 14, 15 have been developed to","constraints can be task specifics, for example, many approaches [11, 12, 13, 14, 15] have been developed to",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"constraints can be task specifics, for example, many approaches 11, 12, 13, 14, 15 have been developed to","constraints can be task specifics, for example, many approaches [11, 12, 13, 14, 15] have been developed to",generate molecules that bind to certain protein binding sites.,generate molecules that bind to certain protein binding sites.,1,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
generate molecules that bind to certain protein binding sites.,generate molecules that bind to certain protein binding sites.,Early computational approaches for molecule generation were mostly applications of generative deep,Early computational approaches for molecule generation were mostly applications of generative deep,1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,2,2,0
Early computational approaches for molecule generation were mostly applications of generative deep,Early computational approaches for molecule generation were mostly applications of generative deep,"learning models, such as variational autoencoder 16. More recently, there was a shift from generations of","learning models, such as variational autoencoder [16]. More recently, there was a shift from generations of",1,-14.94,0,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"learning models, such as variational autoencoder 16. More recently, there was a shift from generations of","learning models, such as variational autoencoder [16]. More recently, there was a shift from generations of","whole molecules all at once, to iterative generations of atoms and bonds 6, 8. Many of such approaches","whole molecules all at once, to iterative generations of atoms and bonds [6, 8]. Many of such approaches",1,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"whole molecules all at once, to iterative generations of atoms and bonds 6, 8. Many of such approaches","whole molecules all at once, to iterative generations of atoms and bonds [6, 8]. Many of such approaches",utilized GNN modules as backbones to generate molecules with specific substructures or with high binding,utilized GNN modules as backbones to generate molecules with specific substructures or with high binding,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
utilized GNN modules as backbones to generate molecules with specific substructures or with high binding,utilized GNN modules as backbones to generate molecules with specific substructures or with high binding,affinity to specific proteins 8.,affinity to specific proteins [8].,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
affinity to specific proteins 8.,affinity to specific proteins [8].,1.2 Molecular Property Prediction,Molecular Property Prediction,5.94,26.9,0,0,0,9.96,11.96,1.99,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,2,2,0
1.2 Molecular Property Prediction,Molecular Property Prediction,"Once drug candidates are selected, researchers need to study drugable properties of candidate molecules,","Once drug candidates are selected, researchers need to study drugable properties of candidate molecules,",3.09,-26.9,0,0,1,11.96,9.96,-1.99,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,2,2,0
"Once drug candidates are selected, researchers need to study drugable properties of candidate molecules,","Once drug candidates are selected, researchers need to study drugable properties of candidate molecules,","such as toxicity and possible adverse effects, water solubility, and binding affinity to target proteins. Experimental studies are slow and costly. With quick accumulation of high-quality training data, a great number","imental studies are slow and costly. With quick accumulation of high-quality training data, a great number",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"such as toxicity and possible adverse effects, water solubility, and binding affinity to target proteins. Experimental studies are slow and costly. With quick accumulation of high-quality training data, a great number","imental studies are slow and costly. With quick accumulation of high-quality training data, a great number","of computational methods for molecular property prediction have been developed 17, 18, 19, 20, the goals","of computational methods for molecular property prediction have been developed [17, 18, 19, 20], the goals",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"of computational methods for molecular property prediction have been developed 17, 18, 19, 20, the goals","of computational methods for molecular property prediction have been developed [17, 18, 19, 20], the goals",of which are to reduce the need for extensive experimental validation and to accelerate the drug discovery,of which are to reduce the need for extensive experimental validation and to accelerate the drug discovery,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
of which are to reduce the need for extensive experimental validation and to accelerate the drug discovery,of which are to reduce the need for extensive experimental validation and to accelerate the drug discovery,process.,process.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
process.,process.,"Molecular properties can be classified into different categories based on their levels, from molecular","Molecular properties can be classified into different categories based on their levels, from molecular",1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,2,2,0
"Molecular properties can be classified into different categories based on their levels, from molecular","Molecular properties can be classified into different categories based on their levels, from molecular","level e.g., quantum mechanics to physiological level 21. Computationally, the tasks of molecular property prediction can be categorized into two broad classes based on their inputs: predictions based on single molecules i.e., drug candidates 17, 22, 23, and predictions of relationships based on two or more","gle molecules (i.e., drug candidates) [17, 22, 23], and predictions of relationships based on two or more",8.84,-14.94,0,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"level e.g., quantum mechanics to physiological level 21. Computationally, the tasks of molecular property prediction can be categorized into two broad classes based on their inputs: predictions based on single molecules i.e., drug candidates 17, 22, 23, and predictions of relationships based on two or more","gle molecules (i.e., drug candidates) [17, 22, 23], and predictions of relationships based on two or more","molecules e.g., drug-target or protein-ligand 24, 25, 26. The predictions based on single molecules can","molecules (e.g., drug-target or protein-ligand) [24, 25, 26]. The predictions based on single molecules can",1,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"molecules e.g., drug-target or protein-ligand 24, 25, 26. The predictions based on single molecules can","molecules (e.g., drug-target or protein-ligand) [24, 25, 26]. The predictions based on single molecules can",be either classification-based or regression-based. The goal of classification tasks is to predict the presence/absence of certain properties. The regression tasks focus on the prediction of the quantitative value of,ence/absence of certain properties. The regression tasks focus on the prediction of the quantitative value of,4.92,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
be either classification-based or regression-based. The goal of classification tasks is to predict the presence/absence of certain properties. The regression tasks focus on the prediction of the quantitative value of,ence/absence of certain properties. The regression tasks focus on the prediction of the quantitative value of,"a particular property of a molecule. Similarly, relationships among molecules 27, 28 can be represented by","a particular property of a molecule. Similarly, relationships among molecules [27, 28] can be represented by",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"a particular property of a molecule. Similarly, relationships among molecules 27, 28 can be represented by","a particular property of a molecule. Similarly, relationships among molecules [27, 28] can be represented by",a binary value or a numerical value. Examples of the former include whether a protein and a target interact.,a binary value or a numerical value. Examples of the former include whether a protein and a target interact.,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
a binary value or a numerical value. Examples of the former include whether a protein and a target interact.,a binary value or a numerical value. Examples of the former include whether a protein and a target interact.,The affinity score between two molecules is an example of the latter.,The affinity score between two molecules is an example of the latter.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,2,2,1
The affinity score between two molecules is an example of the latter.,The affinity score between two molecules is an example of the latter.,"Traditionally, drug property prediction heavily relied on classical machine learning techniques such as","Traditionally, drug property prediction heavily relied on classical machine learning techniques such as",1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,2,2,0
"Traditionally, drug property prediction heavily relied on classical machine learning techniques such as","Traditionally, drug property prediction heavily relied on classical machine learning techniques such as","random forests or support vector machines 2, necessitating deep domain knowledge for feature engineering. With the emergence of deep learning, there was a significant shift towards neural network based models 2, 29. This transition marked a move from one-dimensional string representations of drugs to richer","els [2, 29]. This transition marked a move from one-dimensional string representations of drugs to richer",8.84,-14.94,0,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"random forests or support vector machines 2, necessitating deep domain knowledge for feature engineering. With the emergence of deep learning, there was a significant shift towards neural network based models 2, 29. This transition marked a move from one-dimensional string representations of drugs to richer","els [2, 29]. This transition marked a move from one-dimensional string representations of drugs to richer","two-dimensional graph and three-dimensional conformation models, broadening the scope and accuracy of","two-dimensional graph and three-dimensional conformation models, broadening the scope and accuracy of",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"two-dimensional graph and three-dimensional conformation models, broadening the scope and accuracy of","two-dimensional graph and three-dimensional conformation models, broadening the scope and accuracy of","drug property prediction. In particular, GNNs, which take in a molecular graph representation and directly","drug property prediction. In particular, GNNs, which take in a molecular graph representation and directly",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,2,2,1
"predict molecular properties, have attracted substantial attention in cheminformatics and bioinformatics  e.g.,","predict molecular properties, have attracted substantial attention in cheminformatics and bioinformatics (e.g.,",30,[30]).,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,3,3,1
30,[30]).,1.3 Drug-Drug Interaction Prediction,Drug-Drug Interaction Prediction,5.78,26.9,0,0,0,9.96,11.96,1.99,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,3,3,0
1.3 Drug-Drug Interaction Prediction,Drug-Drug Interaction Prediction,"In the treatment of complex diseases such as cancer and neurological disorders, combinational drug therapies","In the treatment of complex diseases such as cancer and neurological disorders, combinational drug therapies",3.09,-26.9,0,0,1,11.96,9.96,-1.99,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,3,3,0
"In the treatment of complex diseases such as cancer and neurological disorders, combinational drug therapies","In the treatment of complex diseases such as cancer and neurological disorders, combinational drug therapies","have shown promise in improving treatment efficacy by targeting multiple biological pathways simultaneously 4, 31, 32. However, as the number of possible drug combinations grows with the increasing number","ously [4, 31, 32]. However, as the number of possible drug combinations grows with the increasing number",4.92,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"have shown promise in improving treatment efficacy by targeting multiple biological pathways simultaneously 4, 31, 32. However, as the number of possible drug combinations grows with the increasing number","ously [4, 31, 32]. However, as the number of possible drug combinations grows with the increasing number","of available drugs, the potential for undetected and unexpected drug-drug interaction DDIs also rises 33.","of available drugs, the potential for undetected and unexpected drug-drug interaction (DDIs) also rises [33].",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"of available drugs, the potential for undetected and unexpected drug-drug interaction DDIs also rises 33.","of available drugs, the potential for undetected and unexpected drug-drug interaction (DDIs) also rises [33].","Such interactions can lead to reduction of therapeutic effectiveness, adverse side effects 34, and sometimes","Such interactions can lead to reduction of therapeutic effectiveness, adverse side effects [34], and sometimes",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,3,3,1
"Such interactions can lead to reduction of therapeutic effectiveness, adverse side effects 34, and sometimes","Such interactions can lead to reduction of therapeutic effectiveness, adverse side effects [34], and sometimes","increased hospitalization 35, posing significant challenges to the screening and optimization of combinational drug therapies. Therefore, it is crucial to develop methods that can precisely predict the drug-drug","tional drug therapies. Therefore, it is crucial to develop methods that can precisely predict the drug-drug",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"increased hospitalization 35, posing significant challenges to the screening and optimization of combinational drug therapies. Therefore, it is crucial to develop methods that can precisely predict the drug-drug","tional drug therapies. Therefore, it is crucial to develop methods that can precisely predict the drug-drug",synergies and adverse interactions to ensure safer and more effective treatments.,synergies and adverse interactions to ensure safer and more effective treatments.,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
synergies and adverse interactions to ensure safer and more effective treatments.,synergies and adverse interactions to ensure safer and more effective treatments.,"Strictly speaking, drug combination therapies, which rely on synergistic or additive interactions of drugs","Strictly speaking, drug combination therapies, which rely on synergistic or additive interactions of drugs",1,14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,3,3,0
"Strictly speaking, drug combination therapies, which rely on synergistic or additive interactions of drugs","Strictly speaking, drug combination therapies, which rely on synergistic or additive interactions of drugs","to increase efficacy, reduce toxicity, and/or prevent drug resistance, can be treated as one type of drugdrug interactions. In this review, we use the broad definition of drug-drug interactions, which include both","drug interactions. In this review, we use the broad definition of drug-drug interactions, which include both",4.92,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"to increase efficacy, reduce toxicity, and/or prevent drug resistance, can be treated as one type of drugdrug interactions. In this review, we use the broad definition of drug-drug interactions, which include both","drug interactions. In this review, we use the broad definition of drug-drug interactions, which include both","synergistic/additive as well as antagonistic/adverse interactions. To predict drug-drug interactions computationally, the inputs usually include representations of drugs and types of interactions. In the simplest case,","tionally, the inputs usually include representations of drugs and types of interactions. In the simplest case,",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"synergistic/additive as well as antagonistic/adverse interactions. To predict drug-drug interactions computationally, the inputs usually include representations of drugs and types of interactions. In the simplest case,","tionally, the inputs usually include representations of drugs and types of interactions. In the simplest case,",methods may only focus on the prediction of the existence of a particular type of interaction 36. The,methods may only focus on the prediction of the existence of a particular type of interaction [36]. The,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
methods may only focus on the prediction of the existence of a particular type of interaction 36. The,methods may only focus on the prediction of the existence of a particular type of interaction [36]. The,"problem is simply formulated as a binary classification problem. In other cases  e.g., data from cell-based","problem is simply formulated as a binary classification problem. In other cases (e.g., data from cell-based",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"problem is simply formulated as a binary classification problem. In other cases  e.g., data from cell-based","problem is simply formulated as a binary classification problem. In other cases (e.g., data from cell-based","assays, the relationships can be quantified based on one or multiple measures of individual drugs and/or","assays), the relationships can be quantified based on one or multiple measures of individual drugs and/or",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"assays, the relationships can be quantified based on one or multiple measures of individual drugs and/or","assays), the relationships can be quantified based on one or multiple measures of individual drugs and/or","drug pairs e.g., half maximal inhibitory concentration or IC50, which can be viewed as regression tasks.","drug pairs (e.g., half maximal inhibitory concentration or IC50), which can be viewed as regression tasks.",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"drug pairs e.g., half maximal inhibitory concentration or IC50, which can be viewed as regression tasks.","drug pairs (e.g., half maximal inhibitory concentration or IC50), which can be viewed as regression tasks.","Yet in some other cases data from patient-based studies, different criteria or biomarkers  e.g., blood pressure, blood sugar are considered and only a few categorical values  e.g., increasing, no change, decreasing","sure, blood sugar) are considered and only a few categorical values (e.g., increasing, no change, decreasing)",4.92,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,3,3,1
"Yet in some other cases data from patient-based studies, different criteria or biomarkers  e.g., blood pressure, blood sugar are considered and only a few categorical values  e.g., increasing, no change, decreasing","sure, blood sugar) are considered and only a few categorical values (e.g., increasing, no change, decreasing)",are considered for each criterion/biomarker. The problem can be formulated as a multi-class classification,are considered for each criterion/biomarker. The problem can be formulated as a multi-class classification,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
are considered for each criterion/biomarker. The problem can be formulated as a multi-class classification,are considered for each criterion/biomarker. The problem can be formulated as a multi-class classification,problem 37.,problem [37].,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
problem 37.,problem [37].,"Over the years, many computational approaches have been developed for drug-drug interaction predictions 37, 36, 38, 39. Earlier approaches were mostly based on traditional machine learning algorithms","tions [37, 36, 38, 39]. Earlier approaches were mostly based on traditional machine learning algorithms",4.92,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,3,3,0
"Over the years, many computational approaches have been developed for drug-drug interaction predictions 37, 36, 38, 39. Earlier approaches were mostly based on traditional machine learning algorithms","tions [37, 36, 38, 39]. Earlier approaches were mostly based on traditional machine learning algorithms","and/or matrix decomposition framework 38. Some methods 40, 41, 42 can even take into considerations of patients’ medical history and recommend drugs that are safe to use for specific patients. More",tions of patients’ medical history and recommend drugs that are safe to use for specific patients. More,4.92,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"and/or matrix decomposition framework 38. Some methods 40, 41, 42 can even take into considerations of patients’ medical history and recommend drugs that are safe to use for specific patients. More",tions of patients’ medical history and recommend drugs that are safe to use for specific patients. More,"recently, more and more approaches based on deep learning models have drawn increasing attention, and","recently, more and more approaches based on deep learning models have drawn increasing attention, and",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"recently, more and more approaches based on deep learning models have drawn increasing attention, and","recently, more and more approaches based on deep learning models have drawn increasing attention, and","have achieved better performance 38. In particular, with advancements in the development of GNNs,","have achieved better performance [38]. In particular, with advancements in the development of GNNs,",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"have achieved better performance 38. In particular, with advancements in the development of GNNs,","have achieved better performance [38]. In particular, with advancements in the development of GNNs,",methods that adapt GNNs as backbones to incorporate interactions as networks have achieved state-of-theart results 42.,methods that adapt GNNs as backbones to incorporate interactions as networks have achieved state-of-the-,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
methods that adapt GNNs as backbones to incorporate interactions as networks have achieved state-of-theart results 42.,methods that adapt GNNs as backbones to incorporate interactions as networks have achieved state-of-the-,2 Representations of Molecules,Representations of Molecules,10.84,21.52,0,1,0,9.96,14.35,4.38,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,1,0,0,3,3,0
2 Representations of Molecules,Representations of Molecules,"In general, molecules can be represented via fingerprints, the Simplified Molecular Input Line Entry System","In general, molecules can be represented via fingerprints, the Simplified Molecular Input Line Entry System",4.1,-21.52,0,0,1,14.35,9.96,-4.38,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,3,3,0
"In general, molecules can be represented via fingerprints, the Simplified Molecular Input Line Entry System","In general, molecules can be represented via fingerprints, the Simplified Molecular Input Line Entry System","SMILES strings, or 2D-/3D-graphs in Fig. 1. Binary fingerprints representing molecular substructure or","(SMILES) strings, or 2D-/3D-graphs in Fig. 1. Binary fingerprints representing molecular substructure or",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,3,3,1
"SMILES strings, or 2D-/3D-graphs in Fig. 1. Binary fingerprints representing molecular substructure or","(SMILES) strings, or 2D-/3D-graphs in Fig. 1. Binary fingerprints representing molecular substructure or","topology allows efficient computation and database search 43. However, they cannot easily encode global","topology allows efficient computation and database search [43]. However, they cannot easily encode global",1,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"topology allows efficient computation and database search 43. However, they cannot easily encode global","topology allows efficient computation and database search [43]. However, they cannot easily encode global",features of molecules such as size and shape. SMILES is the most widely used linear representation for,features of molecules such as size and shape. SMILES is the most widely used linear representation for,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
features of molecules such as size and shape. SMILES is the most widely used linear representation for,features of molecules such as size and shape. SMILES is the most widely used linear representation for,"describing chemical structures since its invention 44, and is superior to other one-dimensional representation schemes such as binary fingerprints. However, there are innate limitations associated with the internal","tion schemes such as binary fingerprints. However, there are innate limitations associated with the internal",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"describing chemical structures since its invention 44, and is superior to other one-dimensional representation schemes such as binary fingerprints. However, there are innate limitations associated with the internal","tion schemes such as binary fingerprints. However, there are innate limitations associated with the internal",structure of SMILES representations when used in Natural Language Processing NLP algorithms.,structure of SMILES representations when used in Natural Language Processing (NLP) algorithms.,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
structure of SMILES representations when used in Natural Language Processing NLP algorithms.,structure of SMILES representations when used in Natural Language Processing (NLP) algorithms.,"Molecules can be represented as 2D graphs, where nodes represent atoms and edges represent chemical","Molecules can be represented as 2D graphs, where nodes represent atoms and edges represent chemical",1,14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,3,3,0
"Molecules can be represented as 2D graphs, where nodes represent atoms and edges represent chemical","Molecules can be represented as 2D graphs, where nodes represent atoms and edges represent chemical","bonds, or as 3D graphs that also incorporate 3D coordinates, providing detailed spatial information. In","bonds, or as 3D graphs that also incorporate 3D coordinates, providing detailed spatial information. In",1,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,3,3,1
"both cases, both nodes and edges can have their own unique properties or features. While the 2D graph","both cases, both nodes and edges can have their own unique properties or features. While the 2D graph","representation is simpler, 3D representation can better capture interactions based on distances and angles","representation is simpler, 3D representation can better capture interactions based on distances and angles",0.24,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
"representation is simpler, 3D representation can better capture interactions based on distances and angles","representation is simpler, 3D representation can better capture interactions based on distances and angles","between atoms 45, 46, thus providing a more comprehensive view that is crucial for modeling molecular","between atoms [45, 46], thus providing a more comprehensive view that is crucial for modeling molecular",0.24,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
"between atoms 45, 46, thus providing a more comprehensive view that is crucial for modeling molecular","between atoms [45, 46], thus providing a more comprehensive view that is crucial for modeling molecular",dynamics and bindings.,dynamics and bindings.,0.24,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
dynamics and bindings.,dynamics and bindings.,1D Representation 2D Representation 3D Representation,1D Representation,6.38,119.74,0,0,0,9.96,5.6,-4.36,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,4,4,0
1D Representation 2D Representation 3D Representation,1D Representation,SMILE String:,SMILE String:,1.06,5.36,0,0,0,5.6,5.6,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,4,4,1
SMILE String:,SMILE String:,CN1C=NC2=C1C=,CN1C=NC2=C1C(=,0.12,-10.7,0,0,0,5.6,6.6,1,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,4,4,1
CN1C=NC2=C1C=,CN1C=NC2=C1C(=,ONCC=ON2C,O)N(C)C(=O)N2C,0.11,2.75,1,0,0,6.6,6.6,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,4,4,1
ONCC=ON2C,O)N(C)C(=O)N2C,Figure 1: Various molecular representations commonly employed in computational drug discovery models:,Figure 1: Various molecular representations commonly employed in computational drug discovery models:,2.61,-117.15,0,0,1,6.6,9.96,3.36,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,4,4,0
Figure 1: Various molecular representations commonly employed in computational drug discovery models:,Figure 1: Various molecular representations commonly employed in computational drug discovery models:,"1D SMILES strings, 2D molecular graphs, and 3D molecular graphs.","1D SMILES strings, 2D molecular graphs, and 3D molecular graphs.",0.24,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,4,4,1
"1D SMILES strings, 2D molecular graphs, and 3D molecular graphs.","1D SMILES strings, 2D molecular graphs, and 3D molecular graphs.","With molecules intuitively represented as graphs, GNNs offer a natural framework for handling and analyzing molecular data. This synergy has sparked extensive research, positioning GNNs at the forefront of","alyzing molecular data. This synergy has sparked extensive research, positioning GNNs at the forefront of",2.15,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,4,4,0
"With molecules intuitively represented as graphs, GNNs offer a natural framework for handling and analyzing molecular data. This synergy has sparked extensive research, positioning GNNs at the forefront of","alyzing molecular data. This synergy has sparked extensive research, positioning GNNs at the forefront of",innovation in molecular property and interaction prediction. GNNs allow nodes to aggregate information,innovation in molecular property and interaction prediction. GNNs allow nodes to aggregate information,0.24,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
innovation in molecular property and interaction prediction. GNNs allow nodes to aggregate information,innovation in molecular property and interaction prediction. GNNs allow nodes to aggregate information,"through their edges, creating comprehensive graph representations. Furthermore, by combining graph structures with neural networks, GNNs can readily handle both classification and regression tasks 47, 48, 49.","tures with neural networks, GNNs can readily handle both classification and regression tasks [47, 48, 49].",1.2,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
"through their edges, creating comprehensive graph representations. Furthermore, by combining graph structures with neural networks, GNNs can readily handle both classification and regression tasks 47, 48, 49.","tures with neural networks, GNNs can readily handle both classification and regression tasks [47, 48, 49].","Therefore, many innovations in GNNs focus on graph representation learning, rather than specific prediction tasks. Most of the approaches to be discussed in this survey thus can be utilized in many downstream",tion tasks. Most of the approaches to be discussed in this survey thus can be utilized in many downstream,1.2,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,4,4,1
"Therefore, many innovations in GNNs focus on graph representation learning, rather than specific prediction tasks. Most of the approaches to be discussed in this survey thus can be utilized in many downstream",tion tasks. Most of the approaches to be discussed in this survey thus can be utilized in many downstream,applications.,applications.,0.24,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
applications.,applications.,3 Molecule Generation,Molecule Generation,1.72,21.52,0,0,0,9.96,14.35,4.38,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,1,0,0,4,4,0
3 Molecule Generation,Molecule Generation,One of the initial steps in drug discovery involves selecting a set of candidate molecules for early-stage,One of the initial steps in drug discovery involves selecting a set of candidate molecules for early-stage,1,-21.52,0,0,1,14.35,9.96,-4.38,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,4,4,0
One of the initial steps in drug discovery involves selecting a set of candidate molecules for early-stage,One of the initial steps in drug discovery involves selecting a set of candidate molecules for early-stage,"screening. Traditionally, this process has been conducted in laboratories. However, recent advances in computational methods have expanded the toolkit available to researchers, including the use of GNN models","putational methods have expanded the toolkit available to researchers, including the use of GNN models",1.2,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
"screening. Traditionally, this process has been conducted in laboratories. However, recent advances in computational methods have expanded the toolkit available to researchers, including the use of GNN models","putational methods have expanded the toolkit available to researchers, including the use of GNN models",for molecule generation. These models leverage 2D and 3D graph representations of molecules to efficiently generate novel compounds within defined constraints. The development of GNN-based molecule,ciently generate novel compounds within defined constraints. The development of GNN-based molecule,1.2,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
for molecule generation. These models leverage 2D and 3D graph representations of molecules to efficiently generate novel compounds within defined constraints. The development of GNN-based molecule,ciently generate novel compounds within defined constraints. The development of GNN-based molecule,"generation methods can be broadly categorized into three types, as illustrated in Fig. 2: unconstrained generation 6, 7, 50, 51, constrained generation with targeted substructures 8, 10, 9, and ligand-protein-based","eration [6, 7, 50, 51], constrained generation with targeted substructures [8, 10, 9], and ligand-protein-based",1.2,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
"generation methods can be broadly categorized into three types, as illustrated in Fig. 2: unconstrained generation 6, 7, 50, 51, constrained generation with targeted substructures 8, 10, 9, and ligand-protein-based","eration [6, 7, 50, 51], constrained generation with targeted substructures [8, 10, 9], and ligand-protein-based","generation 11, 12, 13, 14, 15. Unconstrained methods prioritize structural diversity, constrained approaches","generation [11, 12, 13, 14, 15]. Unconstrained methods prioritize structural diversity, constrained approaches",0.24,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
"generation 11, 12, 13, 14, 15. Unconstrained methods prioritize structural diversity, constrained approaches","generation [11, 12, 13, 14, 15]. Unconstrained methods prioritize structural diversity, constrained approaches",focus on generating molecules containing specific functional groups or motifs relevant to desired chemical,focus on generating molecules containing specific functional groups or motifs relevant to desired chemical,0.24,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
focus on generating molecules containing specific functional groups or motifs relevant to desired chemical,focus on generating molecules containing specific functional groups or motifs relevant to desired chemical,"or biological properties, and ligand–protein-based strategies are designed to produce molecules that interact","or biological properties, and ligand–protein-based strategies are designed to produce molecules that interact",0.24,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
"or biological properties, and ligand–protein-based strategies are designed to produce molecules that interact","or biological properties, and ligand–protein-based strategies are designed to produce molecules that interact","with specific protein targets. These advances demonstrate the versatility and promise of GNNs in accelerating drug discovery and highlight their pivotal role in identifying novel therapeutic candidates 52, 53, 54, 55.","ing drug discovery and highlight their pivotal role in identifying novel therapeutic candidates [52, 53, 54, 55].",1.2,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,4,4,1
Unconstrained Generation,Unconstrained Generation,Molecule Inputs GNN Blocks Distribution of,Molecule Inputs,-96.89,15.99,0,0,0,11.96,4.9,-7.06,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Molecule Inputs GNN Blocks Distribution of,Molecule Inputs,substructures or,substructures or,1.54,176.75,0,0,1,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
substructures or,substructures or,atoms Sampling,Sampling,1.17,57.37,0,1,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
atoms Sampling,Sampling,Constrained Generation with Specific Substructures,Constrained Generation with Specific Substructures,12.95,-149.61,0,0,1,4.9,4.9,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Constrained Generation with Specific Substructures,Constrained Generation with Specific Substructures,Generated,Generated,-22.46,182.87,0,1,0,4.9,4.9,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Generated,Generated,Results,Results,0.42,3.41,1,0,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Results,Results,Molecule Inputs GNN Blocks Distribution of,Distribution of,-1.55,-91.45,0,0,1,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,0,0,1,0,0,0,0,0,1,5,5,1
Molecule Inputs GNN Blocks Distribution of,Distribution of,substructures or,substructures or,23.7,-3.95,1,1,1,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,1,1,0,0,0,0,0,0,1,5,5,1
substructures or,substructures or,Specific Fixed Generated,Specific Fixed,-4.92,74.2,0,1,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Specific Fixed Generated,Specific Fixed,Substructure Results,Substructure,0.42,1.36,1,0,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Substructure Results,Substructure,Generated,Generate,-3.44,67.84,0,0,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Generated,Generate,Substructure,Substructure,0.42,-67.84,0,0,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Substructure,Substructure,atoms Sampling,Sampling,2.66,33.57,0,0,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,1,0,1,0,0,0,0,0,1,5,5,1
atoms Sampling,Sampling,Ligand-Protein Based Generation,Ligand-Protein Based Generation,12.94,-177.79,0,0,1,4.9,4.9,0,0,0,1,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,1,5,5,1
Ligand-Protein Based Generation,Ligand-Protein Based Generation,Protein Ligand,Protein Ligand,-0.12,-106.23,0,1,0,4.9,4.9,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Protein Ligand,Protein Ligand,Binding Site Input GNN Blocks Distribution of,Binding Site Input,0.42,-3.4,1,0,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Binding Site Input GNN Blocks Distribution of,Binding Site Input,substructures or,substructures or,1.48,177.73,0,0,1,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
substructures or,substructures or,Binding Site Generated,Binding Site,-4.92,76.37,0,1,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Binding Site Generated,Binding Site,Molecule Binding Molecule,Binding Molecule,0.17,58.2,0,0,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
Molecule Binding Molecule,Binding Molecule,GNN Blocks Distribution of Molecule,Distribution of,-25.13,-131.43,0,0,1,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
GNN Blocks Distribution of Molecule,Distribution of,atoms Sampling,Sampling,26.53,105.99,0,1,0,4.9,4.9,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
atoms Sampling,Sampling,Figure 2: The general framework of three different types of molecule generation processes. Molecular,Figure 2: The general framework of three different types of molecule generation processes. Molecular,17.62,-326.85,0,0,1,4.9,9.96,5.06,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,0
Figure 2: The general framework of three different types of molecule generation processes. Molecular,Figure 2: The general framework of three different types of molecule generation processes. Molecular,"graphs and protein-ligand complexes are fed into GNN backbone models, which output the probability","graphs and protein-ligand complexes are fed into GNN backbone models, which output the probability",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
"graphs and protein-ligand complexes are fed into GNN backbone models, which output the probability","graphs and protein-ligand complexes are fed into GNN backbone models, which output the probability","distribution of molecular substructures to be sampled, based on which the models select substructures and","distribution of molecular substructures to be sampled, based on which the models select substructures and",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
"distribution of molecular substructures to be sampled, based on which the models select substructures and","distribution of molecular substructures to be sampled, based on which the models select substructures and",assemble the resulting molecules.,assemble the resulting molecules.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
assemble the resulting molecules.,assemble the resulting molecules.,3.1 Unconstrained Generation,Unconstrained Generation,-88.94,157.77,0,0,1,9.96,4.9,-5.06,0,0,1,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,1,5,5,0
3.1 Unconstrained Generation,Unconstrained Generation,"For computational methods to generate promising drug candidates, a natural approach is to generate chemically valid molecules in the vicinity of existing drugs and drug candidates  i.e., known training data. In","ically valid molecules in the vicinity of existing drugs and drug candidates (i.e., known training data). In",105.08,-157.77,0,1,0,4.9,9.96,5.06,0,1,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,1,5,5,0
"For computational methods to generate promising drug candidates, a natural approach is to generate chemically valid molecules in the vicinity of existing drugs and drug candidates  i.e., known training data. In","ically valid molecules in the vicinity of existing drugs and drug candidates (i.e., known training data). In","other words, computational models are typically trained on “hit molecules”–compounds that already exhibit desirable properties for drug development. Because there are no additional constraints on molecular",hibit desirable properties for drug development. Because there are no additional constraints on molecular,4.92,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
"other words, computational models are typically trained on “hit molecules”–compounds that already exhibit desirable properties for drug development. Because there are no additional constraints on molecular",hibit desirable properties for drug development. Because there are no additional constraints on molecular,"substructures or chemical properties  e.g., binding affinity imposed explicitly, such methods are classified","substructures or chemical properties (e.g., binding affinity) imposed explicitly, such methods are classified",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
"substructures or chemical properties  e.g., binding affinity imposed explicitly, such methods are classified","substructures or chemical properties (e.g., binding affinity) imposed explicitly, such methods are classified",as unconstrained. The primary goal of such approaches is to generate structurally valid and chemically,as unconstrained. The primary goal of such approaches is to generate structurally valid and chemically,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
as unconstrained. The primary goal of such approaches is to generate structurally valid and chemically,as unconstrained. The primary goal of such approaches is to generate structurally valid and chemically,"plausible molecules with high diversity, guided by the distribution of the training data.","plausible molecules with high diversity, guided by the distribution of the training data.",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
"plausible molecules with high diversity, guided by the distribution of the training data.","plausible molecules with high diversity, guided by the distribution of the training data.","GraphINVENT 56 is one of the initial explorations into unconstrained molecular graph generation,","GraphINVENT [56] is one of the initial explorations into unconstrained molecular graph generation,",1,14.94,0,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,5,5,0
"GraphINVENT 56 is one of the initial explorations into unconstrained molecular graph generation,","GraphINVENT [56] is one of the initial explorations into unconstrained molecular graph generation,",which explored various GNN architectures–such as gated GNNs and attention-based GNNs–to learn an,which explored various GNN architectures–such as gated GNNs and attention-based GNNs–to learn an,1,-14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
which explored various GNN architectures–such as gated GNNs and attention-based GNNs–to learn an,which explored various GNN architectures–such as gated GNNs and attention-based GNNs–to learn an,“action” probability distribution from training molecules. The model then iteratively sampled one action at,“action” probability distribution from training molecules. The model then iteratively sampled one action at,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
“action” probability distribution from training molecules. The model then iteratively sampled one action at,“action” probability distribution from training molecules. The model then iteratively sampled one action at,"a time, e.g., adding a bond or an atom, until a “terminate generation” action was reached. Doing so allowed","a time, e.g., adding a bond or an atom, until a “terminate generation” action was reached. Doing so allowed",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
"a time, e.g., adding a bond or an atom, until a “terminate generation” action was reached. Doing so allowed","a time, e.g., adding a bond or an atom, until a “terminate generation” action was reached. Doing so allowed",the approach to construct a molecule step by step. GraphINVENT is a representative among a broader,the approach to construct a molecule step by step. GraphINVENT is a representative among a broader,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
the approach to construct a molecule step by step. GraphINVENT is a representative among a broader,the approach to construct a molecule step by step. GraphINVENT is a representative among a broader,"class of models 57, 58, 59, 60 that all adopt such an iterative sampling strategy that build new graphs by","class of models [57, 58, 59, 60] that all adopt such an iterative sampling strategy that build new graphs by",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
"class of models 57, 58, 59, 60 that all adopt such an iterative sampling strategy that build new graphs by","class of models [57, 58, 59, 60] that all adopt such an iterative sampling strategy that build new graphs by",repeatedly sampling components or actions from learned distributions.,repeatedly sampling components or actions from learned distributions.,1,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
repeatedly sampling components or actions from learned distributions.,repeatedly sampling components or actions from learned distributions.,"Beyond this one-piece-at-a-time paradigm, another type of method adopted generative frameworks that","Beyond this one-piece-at-a-time paradigm, another type of method adopted generative frameworks that",1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,5,5,0
"Beyond this one-piece-at-a-time paradigm, another type of method adopted generative frameworks that","Beyond this one-piece-at-a-time paradigm, another type of method adopted generative frameworks that","produce complete molecules graphs in a single pass. For instance, ConfVAE 61 integrated both 2D","produce complete molecules (graphs) in a single pass. For instance, ConfVAE [61] integrated both 2D",1,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
"produce complete molecules graphs in a single pass. For instance, ConfVAE 61 integrated both 2D","produce complete molecules (graphs) in a single pass. For instance, ConfVAE [61] integrated both 2D","molecular graphs and 3D conformations, ensuring rotational and translational invariance. It employed a","molecular graphs and 3D conformations, ensuring rotational and translational invariance. It employed a",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
"molecular graphs and 3D conformations, ensuring rotational and translational invariance. It employed a","molecular graphs and 3D conformations, ensuring rotational and translational invariance. It employed a","Conditional Variational Autoencoder CVAE framework, with Message Passing Neural Networks MPNNs","Conditional Variational Autoencoder (CVAE) framework, with Message Passing Neural Networks (MPNNs)",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,5,5,1
"Conditional Variational Autoencoder CVAE framework, with Message Passing Neural Networks MPNNs","Conditional Variational Autoencoder (CVAE) framework, with Message Passing Neural Networks (MPNNs)","for graph encoding, enabling end-to-end conditional molecule generation. While ConfVAE leveraged GNNs","for graph encoding, enabling end-to-end conditional molecule generation. While ConfVAE leveraged GNNs",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
"for graph encoding, enabling end-to-end conditional molecule generation. While ConfVAE leveraged GNNs","for graph encoding, enabling end-to-end conditional molecule generation. While ConfVAE leveraged GNNs","within a generative framework, VonMisesNet 7 took a different approach by focusing on capturing the re","within a generative framework, VonMisesNet [7] took a different approach by focusing on capturing the re-",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,5,5,1
alistic distribution of torsional angles in molecules. It introduced a novel GNN architecture that sampled,alistic distribution of torsional angles in molecules. It introduced a novel GNN architecture that sampled,"torsion angles from the Von Mises distribution, which better reflected the physical constraints of molecular","torsion angles from the Von Mises distribution, which better reflected the physical constraints of molecular",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"torsion angles from the Von Mises distribution, which better reflected the physical constraints of molecular","torsion angles from the Von Mises distribution, which better reflected the physical constraints of molecular","geometry. Moreover, VonMisesNet addressed key challenges such as chirality inversion of atoms and supports molecules with a large number of rotatable bonds-enhancing the chemical accuracy and diversity of its",ports molecules with a large number of rotatable bonds-enhancing the chemical accuracy and diversity of its,4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"geometry. Moreover, VonMisesNet addressed key challenges such as chirality inversion of atoms and supports molecules with a large number of rotatable bonds-enhancing the chemical accuracy and diversity of its",ports molecules with a large number of rotatable bonds-enhancing the chemical accuracy and diversity of its,outputs.,outputs.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
outputs.,outputs.,"Overall, unconstrained generation models are increasingly integrating with generative architectures such","Overall, unconstrained generation models are increasingly integrating with generative architectures such",1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,6,6,0
"Overall, unconstrained generation models are increasingly integrating with generative architectures such","Overall, unconstrained generation models are increasingly integrating with generative architectures such","as VAEs and GANs, aiming to better approximate the true data distribution. Nonetheless, as the need grows","as VAEs and GANs, aiming to better approximate the true data distribution. Nonetheless, as the need grows",1,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"as VAEs and GANs, aiming to better approximate the true data distribution. Nonetheless, as the need grows","as VAEs and GANs, aiming to better approximate the true data distribution. Nonetheless, as the need grows","to reduce the cost of candidate selection, improve the quality of generated molecules, and generate molecules","to reduce the cost of candidate selection, improve the quality of generated molecules, and generate molecules",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"to reduce the cost of candidate selection, improve the quality of generated molecules, and generate molecules","to reduce the cost of candidate selection, improve the quality of generated molecules, and generate molecules","that could be synthesized, research is gradually shifting toward generation models that incorporate explicit","that could be synthesized, research is gradually shifting toward generation models that incorporate explicit",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"that could be synthesized, research is gradually shifting toward generation models that incorporate explicit","that could be synthesized, research is gradually shifting toward generation models that incorporate explicit",constraints on substructures and target properties.,constraints on substructures and target properties.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
constraints on substructures and target properties.,constraints on substructures and target properties.,3.2 Constrained Generation with Specific Substructures,Constrained Generation with Specific Substructures,5.94,26.9,0,0,1,9.96,11.96,1.99,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,6,6,0
3.2 Constrained Generation with Specific Substructures,Constrained Generation with Specific Substructures,"In drug development, generating molecules with specific substructures and targeted chemical properties is","In drug development, generating molecules with specific substructures and targeted chemical properties is",3.09,-26.9,0,1,1,11.96,9.96,-1.99,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,6,6,0
"In drug development, generating molecules with specific substructures and targeted chemical properties is","In drug development, generating molecules with specific substructures and targeted chemical properties is","often more desirable than unconstrained molecule generation. MoLeR, introduced by Maziarz et al. 8,","often more desirable than unconstrained molecule generation. MoLeR, introduced by Maziarz et al. [8],",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"often more desirable than unconstrained molecule generation. MoLeR, introduced by Maziarz et al. 8,","often more desirable than unconstrained molecule generation. MoLeR, introduced by Maziarz et al. [8],",demonstrated the capability to perform both constrained and unconstrained molecule generation. It utilized motifs–common chemical substructures–within an encoder-decoder framework. By combining GNN,lized motifs–common chemical substructures–within an encoder-decoder framework. By combining GNN,4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
demonstrated the capability to perform both constrained and unconstrained molecule generation. It utilized motifs–common chemical substructures–within an encoder-decoder framework. By combining GNN,lized motifs–common chemical substructures–within an encoder-decoder framework. By combining GNN,"and Multilayer Perceptron MLP blocks, MoLeR carefully constructed molecules one motif at a time, sequentially selecting motifs or atoms, determining attachment points, and assigning bond types, each step","quentially selecting motifs or atoms, determining attachment points, and assigning bond types, each step",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"and Multilayer Perceptron MLP blocks, MoLeR carefully constructed molecules one motif at a time, sequentially selecting motifs or atoms, determining attachment points, and assigning bond types, each step","quentially selecting motifs or atoms, determining attachment points, and assigning bond types, each step",optimized for molecular validity and functionality.,optimized for molecular validity and functionality.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
optimized for molecular validity and functionality.,optimized for molecular validity and functionality.,"Building on the success of fragment-based approaches like MoLeR, newer models have further advanced","Building on the success of fragment-based approaches like MoLeR, newer models have further advanced",1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,6,6,0
"Building on the success of fragment-based approaches like MoLeR, newer models have further advanced","Building on the success of fragment-based approaches like MoLeR, newer models have further advanced","constrained molecule generation. One such model, GEAM 10, introduced the Graph Information Bottleneck GIB principle to identify substructures most relevant to specific drug properties. GEAM first extracted",neck (GIB) principle to identify substructures most relevant to specific drug properties. GEAM first extracted,4.92,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"constrained molecule generation. One such model, GEAM 10, introduced the Graph Information Bottleneck GIB principle to identify substructures most relevant to specific drug properties. GEAM first extracted",neck (GIB) principle to identify substructures most relevant to specific drug properties. GEAM first extracted,a vocabulary of meaningful substructures and then assembled molecules from this learned vocabulary. A soft,a vocabulary of meaningful substructures and then assembled molecules from this learned vocabulary. A soft,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
a vocabulary of meaningful substructures and then assembled molecules from this learned vocabulary. A soft,a vocabulary of meaningful substructures and then assembled molecules from this learned vocabulary. A soft,"actor-critic SAC reinforcement learning algorithm was used to identify high-quality samples, which were","actor-critic (SAC) reinforcement learning algorithm was used to identify high-quality samples, which were",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"actor-critic SAC reinforcement learning algorithm was used to identify high-quality samples, which were","actor-critic (SAC) reinforcement learning algorithm was used to identify high-quality samples, which were",subsequently mutated through a genetic algorithm GA to produce final molecules that were chemically,subsequently mutated through a genetic algorithm (GA) to produce final molecules that were chemically,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
subsequently mutated through a genetic algorithm GA to produce final molecules that were chemically,subsequently mutated through a genetic algorithm (GA) to produce final molecules that were chemically,valid and aligned with the desired drug properties.,valid and aligned with the desired drug properties.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
valid and aligned with the desired drug properties.,valid and aligned with the desired drug properties.,"While models like MoLeR and GEAM focused primarily on the generation process, MiCam 9 proposed","While models like MoLeR and GEAM focused primarily on the generation process, MiCam [9] proposed",1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,6,6,0
"While models like MoLeR and GEAM focused primarily on the generation process, MiCam 9 proposed","While models like MoLeR and GEAM focused primarily on the generation process, MiCam [9] proposed",a novel strategy for building a chemically “reasonable” motif vocabulary. MiCam addressed the limitation of,a novel strategy for building a chemically “reasonable” motif vocabulary. MiCam addressed the limitation of,1,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
a novel strategy for building a chemically “reasonable” motif vocabulary. MiCam addressed the limitation of,a novel strategy for building a chemically “reasonable” motif vocabulary. MiCam addressed the limitation of,"previous fragment-based methods, which often failed to identify appropriate motifs for molecule generation.","previous fragment-based methods, which often failed to identify appropriate motifs for molecule generation.",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"previous fragment-based methods, which often failed to identify appropriate motifs for molecule generation.","previous fragment-based methods, which often failed to identify appropriate motifs for molecule generation.","Its vocabulary construction involved two phases: in the merging-operation learning phase, the model iteratively merged the most frequent atomic patterns found across molecules to form a preliminary set of motifs.",tively merged the most frequent atomic patterns found across molecules to form a preliminary set of motifs.,4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,6,6,1
"Its vocabulary construction involved two phases: in the merging-operation learning phase, the model iteratively merged the most frequent atomic patterns found across molecules to form a preliminary set of motifs.",tively merged the most frequent atomic patterns found across molecules to form a preliminary set of motifs.,"In the motif-vocabulary construction phase, the model disconnected fragments at learned attachment points,","In the motif-vocabulary construction phase, the model disconnected fragments at learned attachment points,",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,6,6,1
"In the motif-vocabulary construction phase, the model disconnected fragments at learned attachment points,","In the motif-vocabulary construction phase, the model disconnected fragments at learned attachment points,",marking these connection sites with special tokens to preserve the information necessary for molecule assembly. This approach allowed MiCam to flexibly generate molecules either by adding known motifs or by,sembly. This approach allowed MiCam to flexibly generate molecules either by adding known motifs or by,4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
marking these connection sites with special tokens to preserve the information necessary for molecule assembly. This approach allowed MiCam to flexibly generate molecules either by adding known motifs or by,sembly. This approach allowed MiCam to flexibly generate molecules either by adding known motifs or by,extending partially generated structures based on the connection history.,extending partially generated structures based on the connection history.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
extending partially generated structures based on the connection history.,extending partially generated structures based on the connection history.,"Overall, these models share a common strategy of using substructures as modular building blocks, aligning generation objectives with the training loss, and constructing molecules in a stepwise manner. Among","ing generation objectives with the training loss, and constructing molecules in a stepwise manner. Among",4.92,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,6,6,0
"Overall, these models share a common strategy of using substructures as modular building blocks, aligning generation objectives with the training loss, and constructing molecules in a stepwise manner. Among","ing generation objectives with the training loss, and constructing molecules in a stepwise manner. Among","the three, GEAM and MiCam offer greater flexibility in incorporating specific constraints on both substructures and chemical properties, as they allow the use of both atoms and motifs during generation. In contrast,","tures and chemical properties, as they allow the use of both atoms and motifs during generation. In contrast,",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
"the three, GEAM and MiCam offer greater flexibility in incorporating specific constraints on both substructures and chemical properties, as they allow the use of both atoms and motifs during generation. In contrast,","tures and chemical properties, as they allow the use of both atoms and motifs during generation. In contrast,",MoLeR primarily relies on starting from a predefined scaffold.,MoLeR primarily relies on starting from a predefined scaffold.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,6,6,1
MoLeR primarily relies on starting from a predefined scaffold.,MoLeR primarily relies on starting from a predefined scaffold.,3.3 Protein-Ligand based Generation,Protein-Ligand based Generation,5.94,26.9,0,0,0,9.96,11.96,1.99,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,6,6,0
3.3 Protein-Ligand based Generation,Protein-Ligand based Generation,"In addition to generating molecules based solely on training data of individual compounds, researchers","In addition to generating molecules based solely on training data of individual compounds, researchers",3.09,-26.9,0,0,1,11.96,9.96,-1.99,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,6,6,0
"In addition to generating molecules based solely on training data of individual compounds, researchers","In addition to generating molecules based solely on training data of individual compounds, researchers","have developed models that focus on protein binding sites and their associated ligands, addressing a new","have developed models that focus on protein binding sites and their associated ligands, addressing a new",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,6,6,1
set of challenges in drug discovery. Recent advances in GNN-based molecule generation have enabled the,set of challenges in drug discovery. Recent advances in GNN-based molecule generation have enabled the,creation of molecules specifically tailored for target proteins. These models employ GNN blocks to maintain,creation of molecules specifically tailored for target proteins. These models employ GNN blocks to maintain,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
creation of molecules specifically tailored for target proteins. These models employ GNN blocks to maintain,creation of molecules specifically tailored for target proteins. These models employ GNN blocks to maintain,"structural consistency—ensuring robustness against flips, shifts, and rotations—while processing attributes","structural consistency—ensuring robustness against flips, shifts, and rotations—while processing attributes",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
"structural consistency—ensuring robustness against flips, shifts, and rotations—while processing attributes","structural consistency—ensuring robustness against flips, shifts, and rotations—while processing attributes",and 3D coordinates of protein binding sites. Approaches such as the AR model 11 and GraphBP 12,and 3D coordinates of protein binding sites. Approaches such as the AR model [11] and GraphBP [12],1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
and 3D coordinates of protein binding sites. Approaches such as the AR model 11 and GraphBP 12,and 3D coordinates of protein binding sites. Approaches such as the AR model [11] and GraphBP [12],introduced distinct strategies for representing atoms and binding environments.,introduced distinct strategies for representing atoms and binding environments.,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
introduced distinct strategies for representing atoms and binding environments.,introduced distinct strategies for representing atoms and binding environments.,These models adopted various techniques to prioritize contextual representation and resilience to rigid,These models adopted various techniques to prioritize contextual representation and resilience to rigid,1,14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,7,7,0
These models adopted various techniques to prioritize contextual representation and resilience to rigid,These models adopted various techniques to prioritize contextual representation and resilience to rigid,"transformations. For instance, AR combined MLP blocks with an auxiliary network to guide atom generation and bonding decisions, whereas GraphBP utilized spherical coordinates alongside MLPs for sequential atom-by-atom construction. Other notable methods, including Pocket2Mol 13 and FLAG 14,","quential atom-by-atom construction. Other notable methods, including Pocket2Mol [13] and FLAG [14],",8.84,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
"transformations. For instance, AR combined MLP blocks with an auxiliary network to guide atom generation and bonding decisions, whereas GraphBP utilized spherical coordinates alongside MLPs for sequential atom-by-atom construction. Other notable methods, including Pocket2Mol 13 and FLAG 14,","quential atom-by-atom construction. Other notable methods, including Pocket2Mol [13] and FLAG [14],",incorporated auxiliary MLP classifiers and predictors to optimize atom positioning and motif attachment.,incorporated auxiliary MLP classifiers and predictors to optimize atom positioning and motif attachment.,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
incorporated auxiliary MLP classifiers and predictors to optimize atom positioning and motif attachment.,incorporated auxiliary MLP classifiers and predictors to optimize atom positioning and motif attachment.,"Collectively, these strategies significantly improved model robustness and adaptability, representing critical","Collectively, these strategies significantly improved model robustness and adaptability, representing critical",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,7,7,1
"Collectively, these strategies significantly improved model robustness and adaptability, representing critical","Collectively, these strategies significantly improved model robustness and adaptability, representing critical",progress toward customizing molecules for specific protein targets—a key advancement in drug discovery.,progress toward customizing molecules for specific protein targets—a key advancement in drug discovery.,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
progress toward customizing molecules for specific protein targets—a key advancement in drug discovery.,progress toward customizing molecules for specific protein targets—a key advancement in drug discovery.,Each model has distinct strengths: the AR model emphasized specificity and binding affinity optimization for particular protein site structures; GraphBP introduced a dual-diffusion architecture to enhance flexibility; Pocket2Mol achieved greater computational efficiency through conditional 3D coordinate sampling;,ibility; Pocket2Mol achieved greater computational efficiency through conditional 3D coordinate sampling;,8.84,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,7,7,0
Each model has distinct strengths: the AR model emphasized specificity and binding affinity optimization for particular protein site structures; GraphBP introduced a dual-diffusion architecture to enhance flexibility; Pocket2Mol achieved greater computational efficiency through conditional 3D coordinate sampling;,ibility; Pocket2Mol achieved greater computational efficiency through conditional 3D coordinate sampling;,and FLAG leveraged motif-based generation to improve structural realism and diversity.,and FLAG leveraged motif-based generation to improve structural realism and diversity.,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
and FLAG leveraged motif-based generation to improve structural realism and diversity.,and FLAG leveraged motif-based generation to improve structural realism and diversity.,"Beyond generating molecules that bind to specific protein sites, there is also a growing need to generate molecules constrained by a desired 3D binding conformation. In many cases, experimental data reveal","ate molecules constrained by a desired 3D binding conformation. In many cases, experimental data reveal",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,7,7,0
"Beyond generating molecules that bind to specific protein sites, there is also a growing need to generate molecules constrained by a desired 3D binding conformation. In many cases, experimental data reveal","ate molecules constrained by a desired 3D binding conformation. In many cases, experimental data reveal","that certain binding postures are particularly effective for interacting with specific proteins, and generating","that certain binding postures are particularly effective for interacting with specific proteins, and generating",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
"that certain binding postures are particularly effective for interacting with specific proteins, and generating","that certain binding postures are particularly effective for interacting with specific proteins, and generating",candidate molecules that adopt these conformations can greatly accelerate screening. SQUID 15 was the,candidate molecules that adopt these conformations can greatly accelerate screening. SQUID [15] was the,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
candidate molecules that adopt these conformations can greatly accelerate screening. SQUID 15 was the,candidate molecules that adopt these conformations can greatly accelerate screening. SQUID [15] was the,"first model designed to address this challenge. Given a target 3D shape, SQUID encodes the input conformation—treated as an unordered point cloud—into hidden features using GNN layers, and then iteratively","mation—treated as an unordered point cloud—into hidden features using GNN layers, and then iteratively",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
"first model designed to address this challenge. Given a target 3D shape, SQUID encodes the input conformation—treated as an unordered point cloud—into hidden features using GNN layers, and then iteratively","mation—treated as an unordered point cloud—into hidden features using GNN layers, and then iteratively",generates 3D molecular fragments that reconstruct the desired shape fragment-by-fragment.,generates 3D molecular fragments that reconstruct the desired shape fragment-by-fragment.,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
generates 3D molecular fragments that reconstruct the desired shape fragment-by-fragment.,generates 3D molecular fragments that reconstruct the desired shape fragment-by-fragment.,Classes,Classes,22.6,344.9,0,1,0,9.96,2.8,-7.16,0,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,7,7,0
Classes,Classes,Node,Node,-14.57,-172.56,0,0,1,2.8,3.92,1.12,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Node,Node,Embeddings,Embeddings,0.34,-6.21,0,1,1,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Embeddings,Embeddings,activation,activation,0.79,-65.97,0,1,0,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
activation,activation,function,function,0.34,0,1,0,0,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
function,function,Model,Model,-9.11,27.11,0,0,0,3.92,3.92,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Model,Model,GNN layer,GNN layer,1.62,1.22,1,0,0,3.92,3.92,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
GNN layer,GNN layer,2D Molecule,2D Molecule,-0.56,-111.21,0,0,0,3.92,3.92,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
2D Molecule,2D Molecule,3D Molecule,3D Molecule,11.76,0,1,0,0,3.92,3.92,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
3D Molecule,3D Molecule,Multi-molecule,Multi-molecule,13.53,-2.28,1,0,0,3.92,3.92,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Multi-molecule,Multi-molecule,Input,Input,0.34,8.93,0,0,0,3.92,3.92,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Input,Input,Auxiliary,Auxiliary,14.01,-3.49,1,0,0,3.92,3.92,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Auxiliary,Auxiliary,Information,Information,0.31,-2.5,1,0,0,3.92,3.92,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Information,Information,GNN layer,GNN layer,-47.82,64,0,0,0,3.92,3.92,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
GNN layer,GNN layer,activation,activation,17.01,18.97,0,0,0,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
activation,activation,function,function,0.34,0,1,0,0,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
function,function,GNN layer,GNN layer,-5.5,-17.98,0,0,0,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
GNN layer,GNN layer,activation,activation,-13.34,67.1,0,0,1,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
activation,activation,function,function,0.34,0,1,1,1,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
function,function,Training Prediction,Prediction,2.92,244.91,0,1,0,3.92,3.92,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Training Prediction,Prediction,Self-supervised Learning,Self-supervised Learning,11.43,-100.1,0,0,0,3.92,3.92,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Self-supervised Learning,Self-supervised Learning,Pre Training,Training,-7,17.66,0,0,0,3.92,2.8,-1.12,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Pre Training,Training,Tasks,Tasks,10.82,32.57,0,0,0,2.8,3.36,0.56,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Tasks,Tasks,BackBone,BackBone,1.54,-39.14,0,0,0,3.36,3.36,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
BackBone,BackBone,Architecture,Architecture,0.29,-1.68,1,0,0,3.36,3.36,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Architecture,Architecture,Knowledge,Knowledge,1.05,13.61,0,0,0,3.36,3.36,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Knowledge,Knowledge,Transfer,Transfer,0.29,2.33,1,0,0,3.36,3.36,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Transfer,Transfer,Downstream,Downstream,1.85,19.74,0,0,0,3.36,3.36,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Downstream,Downstream,Task,Task,0.27,5.98,0,0,0,3.36,3.36,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Task,Task,BackBone,BackBone,1.5,-39.98,0,0,0,3.36,3.36,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
BackBone,BackBone,Architecture,Architecture,0.29,-1.68,1,0,0,3.36,3.36,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Architecture,Architecture,Learning Strategy,Learning Strategy,-46.73,-4.39,1,0,0,3.36,3.92,0.56,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Learning Strategy,Learning Strategy,Few-shot Learning,Few-shot Learning,2.33,0.43,1,0,0,3.92,3.92,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Few-shot Learning,Few-shot Learning,ML Model,ML Model,4.83,10.31,0,0,0,3.92,2.8,-1.12,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
ML Model,ML Model,Query Set,Query,4.68,2.29,1,0,0,2.8,2.8,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Query Set,Query,Molecular,Molecular,-5.69,-83.2,0,0,1,2.8,3.92,1.12,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Molecular,Molecular,embedding,embedding,0.34,-1.3,1,1,1,3.92,3.92,0,1,1,1,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
embedding,embedding,K-Shots,K-Shots,-5.25,46.15,0,1,0,3.92,2.8,-1.12,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
K-Shots,K-Shots,Support Set …,Support,0.24,0.08,1,0,0,2.8,2.8,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Support Set …,Support,Unlabeled,Unlabeled,20.35,-0.97,1,0,0,2.8,3.36,0.56,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Unlabeled,Unlabeled,Dataset,Dataset,0.27,1.78,1,0,0,3.36,3.36,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Dataset,Dataset,Labeled,Labeled,8.14,-0.19,1,0,0,3.36,3.36,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Labeled,Labeled,Dataset,Dataset,0.27,0.19,1,0,0,3.36,3.36,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Dataset,Dataset,Property,Property,-32.65,121.05,0,0,0,3.36,3.92,0.56,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Property,Property,Prediction,Prediction,7.18,-52.32,0,0,0,3.92,2.8,-1.12,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Prediction,Prediction,GNN layer EmbeddingsNode,Embeddings,-0.46,-178.01,0,0,1,2.8,3.92,1.12,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
GNN layer EmbeddingsNode,Embeddings,activation,activation,0.74,-16.77,0,1,1,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
activation,activation,function,function,0.34,0,1,1,1,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
function,function,Aggregation,Aggregation,-0.43,52.52,0,1,1,3.92,3.08,-0.84,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Aggregation,Aggregation,MLP,MLP,-1.41,173.42,0,1,0,3.08,3.08,0,1,1,1,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
MLP,MLP,GNN layer GNN layer,GNN layer,-5.44,-245.61,0,0,0,3.08,3.92,0.84,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
GNN layer GNN layer,GNN layer,Binding site activation function,activation,16.69,20.27,0,0,1,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Binding site activation function,activation,Node,Node,-19.95,22.39,0,1,1,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Node,Node,Embeddings,Embeddings,15.04,-5.47,0,1,1,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,1
Embeddings,Embeddings,activation,activation,1.33,-65.37,0,1,0,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
activation,activation,function,function,0.31,48.45,0,0,1,3.92,3.92,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
function,function,Figure 3: The general framework for GNN-based drug property and interaction prediction. Three common,Figure 3: The general framework for GNN-based drug property and interaction prediction. Three common,17.9,-149.95,0,1,1,3.92,9.96,6.04,0,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,7,7,0
Figure 3: The general framework for GNN-based drug property and interaction prediction. Three common,Figure 3: The general framework for GNN-based drug property and interaction prediction. Three common,"types of inputs are used individually or jointly: 2D molecule graphs, 3D molecule graphs, multi-molecule","types of inputs are used individually or jointly: 2D molecule graphs, 3D molecule graphs, multi-molecule",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
"types of inputs are used individually or jointly: 2D molecule graphs, 3D molecule graphs, multi-molecule","types of inputs are used individually or jointly: 2D molecule graphs, 3D molecule graphs, multi-molecule","interaction graphs such as protein-ligand complexes. Additional auxiliary information can also be incorporated by some approaches. These inputs are then fed into GNN models, which aggregate information from","rated by some approaches. These inputs are then fed into GNN models, which aggregate information from",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
"interaction graphs such as protein-ligand complexes. Additional auxiliary information can also be incorporated by some approaches. These inputs are then fed into GNN models, which aggregate information from","rated by some approaches. These inputs are then fed into GNN models, which aggregate information from","neighboring nodes and produced final latent node representations. To alleviate the label sparsity issue, various learning strategies, such as few-shot learning or self-supervised learning, are widely adopted.","ous learning strategies, such as few-shot learning or self-supervised learning, are widely adopted.",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,7,7,1
4 Prediction of Molecular Properties and Interactions,Prediction of Molecular Properties and Interactions,"In this section, we review various GNN-based approaches for predicting molecular properties and interactions. Different algorithms have been developed for different applications, each utilizing varying types of","tions. Different algorithms have been developed for different applications, each utilizing varying types of",8.03,-21.52,0,1,1,14.35,9.96,-4.38,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,1,0,0,0,8,8,0
"In this section, we review various GNN-based approaches for predicting molecular properties and interactions. Different algorithms have been developed for different applications, each utilizing varying types of","tions. Different algorithms have been developed for different applications, each utilizing varying types of","inputs. Common types of input data include 2D molecular graphs, 3D molecular conformations, multimolecule complexes, and potentially additional auxiliary information Fig. 3.","molecule complexes, and potentially additional auxiliary information (Fig. 3).",4.92,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"inputs. Common types of input data include 2D molecular graphs, 3D molecular conformations, multimolecule complexes, and potentially additional auxiliary information Fig. 3.","molecule complexes, and potentially additional auxiliary information (Fig. 3).",A key component shared by all approaches is the learning of a latent molecular representation through,A key component shared by all approaches is the learning of a latent molecular representation through,1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,8,8,0
A key component shared by all approaches is the learning of a latent molecular representation through,A key component shared by all approaches is the learning of a latent molecular representation through,"GNNs, which is subsequently used for prediction tasks. To address challenges such as label sparsity, many","GNNs, which is subsequently used for prediction tasks. To address challenges such as label sparsity, many",1,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,8,8,1
"GNNs, which is subsequently used for prediction tasks. To address challenges such as label sparsity, many","GNNs, which is subsequently used for prediction tasks. To address challenges such as label sparsity, many","methods also incorporate advanced learning strategies, including self-supervised pre-training and few-shot","methods also incorporate advanced learning strategies, including self-supervised (pre-training) and few-shot",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"methods also incorporate advanced learning strategies, including self-supervised pre-training and few-shot","methods also incorporate advanced learning strategies, including self-supervised (pre-training) and few-shot","learning. In this section, we categorize and discuss these approaches based on their specific prediction tasks","learning. In this section, we categorize and discuss these approaches based on their specific prediction tasks",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"learning. In this section, we categorize and discuss these approaches based on their specific prediction tasks","learning. In this section, we categorize and discuss these approaches based on their specific prediction tasks","and input data types, highlighting their novel contributions and offering insights into how they advance the","and input data types, highlighting their novel contributions and offering insights into how they advance the",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"and input data types, highlighting their novel contributions and offering insights into how they advance the","and input data types, highlighting their novel contributions and offering insights into how they advance the",field.,field.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
field.,field.,4.1 Property Prediction and Molecule Representation Learning Based on 2D Graphs,Property Prediction and Molecule Representation Learning Based on 2D Graphs,5.94,26.9,0,0,1,9.96,11.96,1.99,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,8,8,0
4.1 Property Prediction and Molecule Representation Learning Based on 2D Graphs,Property Prediction and Molecule Representation Learning Based on 2D Graphs,"Learning effective molecular representations is a fundamental step in property prediction. Generally, the","Learning effective molecular representations is a fundamental step in property prediction. Generally, the",3.09,-26.9,0,1,1,11.96,9.96,-1.99,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,8,8,0
"Learning effective molecular representations is a fundamental step in property prediction. Generally, the","Learning effective molecular representations is a fundamental step in property prediction. Generally, the","goal of molecular representation learning is to embed molecules into numerical vectors in a latent space,","goal of molecular representation learning is to embed molecules into numerical vectors in a latent space,",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"goal of molecular representation learning is to embed molecules into numerical vectors in a latent space,","goal of molecular representation learning is to embed molecules into numerical vectors in a latent space,","enabling a variety of downstream tasks 17. Therefore, much of the innovation in property prediction from","enabling a variety of downstream tasks [17]. Therefore, much of the innovation in property prediction from",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"enabling a variety of downstream tasks 17. Therefore, much of the innovation in property prediction from","enabling a variety of downstream tasks [17]. Therefore, much of the innovation in property prediction from","2D graphs lies in the strategies developed for learning molecular representations, which is the focus of this","2D graphs lies in the strategies developed for learning molecular representations, which is the focus of this",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,0,0,0,0,1,0,0,0,1,8,8,1
"2D graphs lies in the strategies developed for learning molecular representations, which is the focus of this","2D graphs lies in the strategies developed for learning molecular representations, which is the focus of this",subsection.,subsection.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
subsection.,subsection.,"When molecules are represented as 2D graphs, early studies typically employed MPNNs 62, wherein","When molecules are represented as 2D graphs, early studies typically employed MPNNs [62], wherein",1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,8,8,0
"When molecules are represented as 2D graphs, early studies typically employed MPNNs 62, wherein","When molecules are represented as 2D graphs, early studies typically employed MPNNs [62], wherein","nodes atoms exchange messages with neighboring nodes, aggregating this information to update their","nodes (atoms) exchange messages with neighboring nodes, aggregating this information to update their",1,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"nodes atoms exchange messages with neighboring nodes, aggregating this information to update their","nodes (atoms) exchange messages with neighboring nodes, aggregating this information to update their","respective states. However, obtaining class labels or quantitative measurements often requires costly laboratory experiments or human annotations. As a result, many datasets contain large numbers of unlabeled or","ratory experiments or human annotations. As a result, many datasets contain large numbers of unlabeled or",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"respective states. However, obtaining class labels or quantitative measurements often requires costly laboratory experiments or human annotations. As a result, many datasets contain large numbers of unlabeled or","ratory experiments or human annotations. As a result, many datasets contain large numbers of unlabeled or","imbalanced samples. To address this, newer approaches often incorporate pre-training strategies or rely on","imbalanced samples. To address this, newer approaches often incorporate pre-training strategies or rely on",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"imbalanced samples. To address this, newer approaches often incorporate pre-training strategies or rely on","imbalanced samples. To address this, newer approaches often incorporate pre-training strategies or rely on",few-shot learning.,few-shot learning.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
few-shot learning.,few-shot learning.,4.1.1 Pre-training,Pre-training,5.74,29.89,0,0,0,9.96,9.96,0,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,8,8,0
4.1.1 Pre-training,Pre-training,"Pre-training 1 has emerged as a promising technique to mitigate label scarcity and is widely adopted in modern GNN models for molecular property prediction. For example, MGSSL 63 introduced a motif-based","ern GNN models for molecular property prediction. For example, MGSSL [63] introduced a motif-based",7.15,-29.89,0,0,0,9.96,9.96,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,8,8,0
"Pre-training 1 has emerged as a promising technique to mitigate label scarcity and is widely adopted in modern GNN models for molecular property prediction. For example, MGSSL 63 introduced a motif-based","ern GNN models for molecular property prediction. For example, MGSSL [63] introduced a motif-based",graph self-supervised learning framework that exploited rich information in subgraphs often overlooked at,graph self-supervised learning framework that exploited rich information in subgraphs often overlooked at,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
graph self-supervised learning framework that exploited rich information in subgraphs often overlooked at,graph self-supervised learning framework that exploited rich information in subgraphs often overlooked at,"the node level. In this setting, the choice of molecular fragmentation method is critical, as poor fragmentation","the node level. In this setting, the choice of molecular fragmentation method is critical, as poor fragmentation",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"the node level. In this setting, the choice of molecular fragmentation method is critical, as poor fragmentation","the node level. In this setting, the choice of molecular fragmentation method is critical, as poor fragmentation",can lead to suboptimal motif generation and degraded model performance.,can lead to suboptimal motif generation and degraded model performance.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
can lead to suboptimal motif generation and degraded model performance.,can lead to suboptimal motif generation and degraded model performance.,"Many other methods adopt contrastive graph learning as their pre-training strategy. MoCL 18, for instance, utilized knowledge-aware contrastive learning informed by local and global domain knowledge. Local domain knowledge ensured semantic invariance during augmentation, while global domain knowledge","cal domain knowledge ensured semantic invariance during augmentation, while global domain knowledge",8.84,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,8,8,0
"Many other methods adopt contrastive graph learning as their pre-training strategy. MoCL 18, for instance, utilized knowledge-aware contrastive learning informed by local and global domain knowledge. Local domain knowledge ensured semantic invariance during augmentation, while global domain knowledge","cal domain knowledge ensured semantic invariance during augmentation, while global domain knowledge","infused structural similarity across the learning process. Nevertheless, designing augmentation schemes that","infused structural similarity across the learning process. Nevertheless, designing augmentation schemes that",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"infused structural similarity across the learning process. Nevertheless, designing augmentation schemes that","infused structural similarity across the learning process. Nevertheless, designing augmentation schemes that","generalize across diverse molecular structures remains challenging. KCL 64 combined contrastive learning with domain-specific knowledge graphs, offering tailored augmentations at the cost of generalizability.","ing with domain-specific knowledge graphs, offering tailored augmentations at the cost of generalizability.",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"generalize across diverse molecular structures remains challenging. KCL 64 combined contrastive learning with domain-specific knowledge graphs, offering tailored augmentations at the cost of generalizability.","ing with domain-specific knowledge graphs, offering tailored augmentations at the cost of generalizability.","MCHNN 65 applied multi-view contrastive learning with task-specific augmentations, enhancing the expressiveness of molecular representations. HiMol 66 advanced self-supervised learning by proposing a",pressiveness of molecular representations. HiMol [66] advanced self-supervised learning by proposing a,4.92,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,8,8,1
"MCHNN 65 applied multi-view contrastive learning with task-specific augmentations, enhancing the expressiveness of molecular representations. HiMol 66 advanced self-supervised learning by proposing a",pressiveness of molecular representations. HiMol [66] advanced self-supervised learning by proposing a,"hierarchical GNN that captured node, motif, and graph-level representations. However, constructing motif","hierarchical GNN that captured node, motif, and graph-level representations. However, constructing motif",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"hierarchical GNN that captured node, motif, and graph-level representations. However, constructing motif","hierarchical GNN that captured node, motif, and graph-level representations. However, constructing motif","dictionaries can be computationally intensive, especially for large molecular databases.","dictionaries can be computationally intensive, especially for large molecular databases.",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
"dictionaries can be computationally intensive, especially for large molecular databases.","dictionaries can be computationally intensive, especially for large molecular databases.","1 Here, pre-training refers to self-supervised learning on the input data itself or its augmented versions, differing slightly from the","1Here, pre-training refers to self-supervised learning on the input data itself or its augmented versions, differing slightly from the",2.95,10.86,0,1,0,9.96,5.98,-3.98,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,8,8,0
"1 Here, pre-training refers to self-supervised learning on the input data itself or its augmented versions, differing slightly from the","1Here, pre-training refers to self-supervised learning on the input data itself or its augmented versions, differing slightly from the",conventional notion in transfer learning where models are first trained on large independent datasets.,conventional notion in transfer learning where models are first trained on large independent datasets.,1.83,-10.86,0,0,1,5.98,7.97,1.99,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,8,8,1
4.1.2 Few-shot Learning,Few-shot Learning,Few-shot learning approaches aim to predict molecular properties with minimal labeled data 67. HSLRG 19 explored both global and local structural semantics for few-shot learning: global information was,RG [19] explored both global and local structural semantics for few-shot learning: global information was,7.15,-29.89,0,0,0,9.96,9.96,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,9,9,0
Few-shot learning approaches aim to predict molecular properties with minimal labeled data 67. HSLRG 19 explored both global and local structural semantics for few-shot learning: global information was,RG [19] explored both global and local structural semantics for few-shot learning: global information was,"captured via molecular relation graphs built from graph kernels, while local information was learned through","captured via molecular relation graphs built from graph kernels, while local information was learned through",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"captured via molecular relation graphs built from graph kernels, while local information was learned through","captured via molecular relation graphs built from graph kernels, while local information was learned through","transformation-invariant representations. Similarly, MHNfs 68 employed a context module that retrieved","transformation-invariant representations. Similarly, MHNfs [68] employed a context module that retrieved",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"transformation-invariant representations. Similarly, MHNfs 68 employed a context module that retrieved","transformation-invariant representations. Similarly, MHNfs [68] employed a context module that retrieved","and enriched molecule representations from a large pool of reference molecules, although the requirement","and enriched molecule representations from a large pool of reference molecules, although the requirement",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"and enriched molecule representations from a large pool of reference molecules, although the requirement","and enriched molecule representations from a large pool of reference molecules, although the requirement",for such large reference sets may limit its practical use.,for such large reference sets may limit its practical use.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
for such large reference sets may limit its practical use.,for such large reference sets may limit its practical use.,"GS-Meta 69 extended few-shot learning to simultaneously handle multiple properties or labels. PACIA 20 introduced hypernetworks to generate adaptive parameters for modulating the GNN encoder,","CIA [20] introduced hypernetworks to generate adaptive parameters for modulating the GNN encoder,",4.92,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,9,9,0
"GS-Meta 69 extended few-shot learning to simultaneously handle multiple properties or labels. PACIA 20 introduced hypernetworks to generate adaptive parameters for modulating the GNN encoder,","CIA [20] introduced hypernetworks to generate adaptive parameters for modulating the GNN encoder,","reducing overfitting while maintaining flexibility. However, designing effective hypernetworks demands","reducing overfitting while maintaining flexibility. However, designing effective hypernetworks demands",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"reducing overfitting while maintaining flexibility. However, designing effective hypernetworks demands","reducing overfitting while maintaining flexibility. However, designing effective hypernetworks demands",significant domain expertise and may constrain the method’s generalizability across tasks. An alternative,significant domain expertise and may constrain the method’s generalizability across tasks. An alternative,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
significant domain expertise and may constrain the method’s generalizability across tasks. An alternative,significant domain expertise and may constrain the method’s generalizability across tasks. An alternative,"strategy to combat label scarcity involves grammar-based generation, as exemplified by Geo-DEG 70,","strategy to combat label scarcity involves grammar-based generation, as exemplified by Geo-DEG [70],",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"strategy to combat label scarcity involves grammar-based generation, as exemplified by Geo-DEG 70,","strategy to combat label scarcity involves grammar-based generation, as exemplified by Geo-DEG [70],","which employed a hierarchical molecular grammar to create molecular graphs, using production paths as","which employed a hierarchical molecular grammar to create molecular graphs, using production paths as",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"which employed a hierarchical molecular grammar to create molecular graphs, using production paths as","which employed a hierarchical molecular grammar to create molecular graphs, using production paths as",informative priors for structural similarity.,informative priors for structural similarity.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
informative priors for structural similarity.,informative priors for structural similarity.,4.1.3 Incorporating Auxiliary Information,Incorporating Auxiliary Information,5.74,29.89,0,0,0,9.96,9.96,0,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,9,9,0
4.1.3 Incorporating Auxiliary Information,Incorporating Auxiliary Information,"Beyond the standard 2D graph representation, researchers have explored integrating additional molecular","Beyond the standard 2D graph representation, researchers have explored integrating additional molecular",3.23,-29.89,0,0,1,9.96,9.96,0,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,9,9,0
"Beyond the standard 2D graph representation, researchers have explored integrating additional molecular","Beyond the standard 2D graph representation, researchers have explored integrating additional molecular","information during learning. For example, PhysChem 22 showed that incorporating physical and chemical","information during learning. For example, PhysChem [22] showed that incorporating physical and chemical",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"information during learning. For example, PhysChem 22 showed that incorporating physical and chemical","information during learning. For example, PhysChem [22] showed that incorporating physical and chemical","properties improved molecular representations, though its cooperation mechanism was less interpretable","properties improved molecular representations, though its cooperation mechanism was less interpretable",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"properties improved molecular representations, though its cooperation mechanism was less interpretable","properties improved molecular representations, though its cooperation mechanism was less interpretable","than traditional ensemble strategies. O-GNN 23 incorporated ring priors into the modeling, leveraging their","than traditional ensemble strategies. O-GNN [23] incorporated ring priors into the modeling, leveraging their",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"than traditional ensemble strategies. O-GNN 23 incorporated ring priors into the modeling, leveraging their","than traditional ensemble strategies. O-GNN [23] incorporated ring priors into the modeling, leveraging their",importance in determining molecular properties. MoleOOD 71 introduced invariant substructure learning,importance in determining molecular properties. MoleOOD [71] introduced invariant substructure learning,1,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
importance in determining molecular properties. MoleOOD 71 introduced invariant substructure learning,importance in determining molecular properties. MoleOOD [71] introduced invariant substructure learning,"to better handle distribution shifts across environments. However, in datasets with large environmental","to better handle distribution shifts across environments. However, in datasets with large environmental",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"to better handle distribution shifts across environments. However, in datasets with large environmental","to better handle distribution shifts across environments. However, in datasets with large environmental","variations, MoleOOD’s advantage over simpler methods like ERM 72 may diminish.","variations, MoleOOD’s advantage over simpler methods like ERM [72] may diminish.",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"variations, MoleOOD’s advantage over simpler methods like ERM 72 may diminish.","variations, MoleOOD’s advantage over simpler methods like ERM [72] may diminish.","Some recent methods have also integrated both one-dimensional sequential encodings  e.g., SMILES","Some recent methods have also integrated both one-dimensional sequential encodings (e.g., SMILES",1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,9,9,0
"Some recent methods have also integrated both one-dimensional sequential encodings  e.g., SMILES","Some recent methods have also integrated both one-dimensional sequential encodings (e.g., SMILES","strings and 2D graphs to jointly leverage information from both views. DVMP 73, for instance, encoded","strings) and 2D graphs to jointly leverage information from both views. DVMP [73], for instance, encoded",1,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"strings and 2D graphs to jointly leverage information from both views. DVMP 73, for instance, encoded","strings) and 2D graphs to jointly leverage information from both views. DVMP [73], for instance, encoded","molecular graphs via GNNs and SMILES sequences via Transformers, using a dual-view consistency loss","molecular graphs via GNNs and SMILES sequences via Transformers, using a dual-view consistency loss",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"molecular graphs via GNNs and SMILES sequences via Transformers, using a dual-view consistency loss","molecular graphs via GNNs and SMILES sequences via Transformers, using a dual-view consistency loss","to maintain semantic coherence. However, involving both Transformer and GNN branches significantly","to maintain semantic coherence. However, involving both Transformer and GNN branches significantly",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"to maintain semantic coherence. However, involving both Transformer and GNN branches significantly","to maintain semantic coherence. However, involving both Transformer and GNN branches significantly",increases training costs compared to single-branch models.,increases training costs compared to single-branch models.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
increases training costs compared to single-branch models.,increases training costs compared to single-branch models.,4.2 Property Prediction based on 3D-graphs,Property Prediction based on 3D-graphs,5.94,26.9,0,0,0,9.96,11.96,1.99,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,9,9,0
4.2 Property Prediction based on 3D-graphs,Property Prediction based on 3D-graphs,"Recent advancements in deep learning and molecular science, driven by the increasing availability of largescale 3D molecular datasets, have significantly advanced property prediction based on 3D molecular graphs.","scale 3D molecular datasets, have significantly advanced property prediction based on 3D molecular graphs.",7.01,-26.9,0,0,1,11.96,9.96,-1.99,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,9,9,0
"Recent advancements in deep learning and molecular science, driven by the increasing availability of largescale 3D molecular datasets, have significantly advanced property prediction based on 3D molecular graphs.","scale 3D molecular datasets, have significantly advanced property prediction based on 3D molecular graphs.","SphereNet 45 introduced an innovative approach for 3D molecular representation learning, proposing a","SphereNet [45] introduced an innovative approach for 3D molecular representation learning, proposing a",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,9,9,1
"SphereNet 45 introduced an innovative approach for 3D molecular representation learning, proposing a","SphereNet [45] introduced an innovative approach for 3D molecular representation learning, proposing a",spherical message-passing scheme that explicitly incorporates 3D spatial information. While SphereNet,spherical message-passing scheme that explicitly incorporates 3D spatial information. While SphereNet,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
spherical message-passing scheme that explicitly incorporates 3D spatial information. While SphereNet,spherical message-passing scheme that explicitly incorporates 3D spatial information. While SphereNet,"demonstrated strong predictive performance, it lacked transparency and interpretability, which hinders the","demonstrated strong predictive performance, it lacked transparency and interpretability, which hinders the",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"demonstrated strong predictive performance, it lacked transparency and interpretability, which hinders the","demonstrated strong predictive performance, it lacked transparency and interpretability, which hinders the",understanding of its decision-making processes. MolKGNN 74 addressed this limitation in the context,understanding of its decision-making processes. MolKGNN [74] addressed this limitation in the context,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
understanding of its decision-making processes. MolKGNN 74 addressed this limitation in the context,understanding of its decision-making processes. MolKGNN [74] addressed this limitation in the context,of quantitative structure–activity relationship QSAR modeling. It enhanced 3D molecular representation,of quantitative structure–activity relationship (QSAR) modeling. It enhanced 3D molecular representation,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
of quantitative structure–activity relationship QSAR modeling. It enhanced 3D molecular representation,of quantitative structure–activity relationship (QSAR) modeling. It enhanced 3D molecular representation,"learning by employing molecular graph convolution with learnable molecular kernels, effectively capturing","learning by employing molecular graph convolution with learnable molecular kernels, effectively capturing",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"learning by employing molecular graph convolution with learnable molecular kernels, effectively capturing","learning by employing molecular graph convolution with learnable molecular kernels, effectively capturing","chemical patterns. Importantly, MolKGNN incorporated molecular chirality, a critical aspect often neglected","chemical patterns. Importantly, MolKGNN incorporated molecular chirality, a critical aspect often neglected",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"chemical patterns. Importantly, MolKGNN incorporated molecular chirality, a critical aspect often neglected","chemical patterns. Importantly, MolKGNN incorporated molecular chirality, a critical aspect often neglected","in previous models. However, the method emphasizes distinguishing specific molecular substructures, which","in previous models. However, the method emphasizes distinguishing specific molecular substructures, which",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
"in previous models. However, the method emphasizes distinguishing specific molecular substructures, which","in previous models. However, the method emphasizes distinguishing specific molecular substructures, which",may limit its generalizability across diverse chemical variations encountered in practical drug discovery,may limit its generalizability across diverse chemical variations encountered in practical drug discovery,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
may limit its generalizability across diverse chemical variations encountered in practical drug discovery,may limit its generalizability across diverse chemical variations encountered in practical drug discovery,scenarios.,scenarios.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
scenarios.,scenarios.,Several studies have explored integrating both 2D and 3D information for property prediction. For,Several studies have explored integrating both 2D and 3D information for property prediction. For,1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,9,9,0
Several studies have explored integrating both 2D and 3D information for property prediction. For,Several studies have explored integrating both 2D and 3D information for property prediction. For,"instance, GraphMVP 75 developed a 2D graph encoder enriched by discriminative 3D geometric informa","instance, GraphMVP [75] developed a 2D graph encoder enriched by discriminative 3D geometric informa-",1,-14.94,0,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,9,9,1
tion. It employed a self-supervised pre-training strategy that leveraged the correspondence and consistency,tion. It employed a self-supervised pre-training strategy that leveraged the correspondence and consistency,"between 2D topologies and 3D conformations. Similarly, 3D-Informax 30 proposed a transfer learning","between 2D topologies and 3D conformations. Similarly, 3D-Informax [30] proposed a transfer learning",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"between 2D topologies and 3D conformations. Similarly, 3D-Informax 30 proposed a transfer learning","between 2D topologies and 3D conformations. Similarly, 3D-Informax [30] proposed a transfer learning","framework that pre-trained on molecules with both 2D and 3D data and then transferred the learned knowledge to molecules with only 2D structures. However, such approaches may risk overfitting, as evidenced by","edge to molecules with only 2D structures. However, such approaches may risk overfitting, as evidenced by",4.92,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"framework that pre-trained on molecules with both 2D and 3D data and then transferred the learned knowledge to molecules with only 2D structures. However, such approaches may risk overfitting, as evidenced by","edge to molecules with only 2D structures. However, such approaches may risk overfitting, as evidenced by",performance variability across different datasets.,performance variability across different datasets.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
performance variability across different datasets.,performance variability across different datasets.,UnifiedPML 76 further improved representation learning by jointly considering 2D and 3D information,UnifiedPML [76] further improved representation learning by jointly considering 2D and 3D information,1,14.94,0,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,10,10,0
UnifiedPML 76 further improved representation learning by jointly considering 2D and 3D information,UnifiedPML [76] further improved representation learning by jointly considering 2D and 3D information,in its pre-training scheme. The framework employed three complementary tasks: reconstruction of masked,in its pre-training scheme. The framework employed three complementary tasks: reconstruction of masked,1,-14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
in its pre-training scheme. The framework employed three complementary tasks: reconstruction of masked,in its pre-training scheme. The framework employed three complementary tasks: reconstruction of masked,"atoms and coordinates, generation of 3D conformations conditioned on 2D graphs, and generation of 2D","atoms and coordinates, generation of 3D conformations conditioned on 2D graphs, and generation of 2D",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"atoms and coordinates, generation of 3D conformations conditioned on 2D graphs, and generation of 2D","atoms and coordinates, generation of 3D conformations conditioned on 2D graphs, and generation of 2D",graphs conditioned on 3D conformations. GeomGCL 77 adopted a dual-channel message-passing neural,graphs conditioned on 3D conformations. GeomGCL [77] adopted a dual-channel message-passing neural,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
graphs conditioned on 3D conformations. GeomGCL 77 adopted a dual-channel message-passing neural,graphs conditioned on 3D conformations. GeomGCL [77] adopted a dual-channel message-passing neural,network to effectively capture both topological and geometric features of molecular graphs.,network to effectively capture both topological and geometric features of molecular graphs.,1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
network to effectively capture both topological and geometric features of molecular graphs.,network to effectively capture both topological and geometric features of molecular graphs.,MoleculeSDE 78 unified 2D and 3D molecular representations by treating them as separate modalities,MoleculeSDE [78] unified 2D and 3D molecular representations by treating them as separate modalities,1,14.94,0,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,10,10,0
MoleculeSDE 78 unified 2D and 3D molecular representations by treating them as separate modalities,MoleculeSDE [78] unified 2D and 3D molecular representations by treating them as separate modalities,in a multi-modal pre-training framework. 3D-PGT 79 proposed a generative pre-training approach on 3D,in a multi-modal pre-training framework. 3D-PGT [79] proposed a generative pre-training approach on 3D,1,-14.94,0,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
in a multi-modal pre-training framework. 3D-PGT 79 proposed a generative pre-training approach on 3D,in a multi-modal pre-training framework. 3D-PGT [79] proposed a generative pre-training approach on 3D,"molecular graphs, which was subsequently fine-tuned on molecules lacking 3D structural data. It employed","molecular graphs, which was subsequently fine-tuned on molecules lacking 3D structural data. It employed",1,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"molecular graphs, which was subsequently fine-tuned on molecules lacking 3D structural data. It employed","molecular graphs, which was subsequently fine-tuned on molecules lacking 3D structural data. It employed","a multi-task learning strategy based on three geometric descriptors–bond lengths, bond angles, and dihedral","a multi-task learning strategy based on three geometric descriptors–bond lengths, bond angles, and dihedral",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"a multi-task learning strategy based on three geometric descriptors–bond lengths, bond angles, and dihedral","a multi-task learning strategy based on three geometric descriptors–bond lengths, bond angles, and dihedral","angles–and used total molecular energy as an optimization target. While promising, the effectiveness of this","angles–and used total molecular energy as an optimization target. While promising, the effectiveness of this",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"angles–and used total molecular energy as an optimization target. While promising, the effectiveness of this","angles–and used total molecular energy as an optimization target. While promising, the effectiveness of this","framework remains to be validated on larger and more structurally complex molecules, as current evaluations","framework remains to be validated on larger and more structurally complex molecules, as current evaluations",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"framework remains to be validated on larger and more structurally complex molecules, as current evaluations","framework remains to be validated on larger and more structurally complex molecules, as current evaluations",have primarily focused on small molecules.,have primarily focused on small molecules.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
have primarily focused on small molecules.,have primarily focused on small molecules.,4.3 Interaction Prediction,Interaction Prediction,5.94,26.9,0,0,0,9.96,11.96,1.99,0,0,1,0,0,0,0,0,1,1,1,0,0,0,0,1,0,0,0,1,10,10,0
4.3 Interaction Prediction,Interaction Prediction,"Beyond property prediction, interaction prediction has been extensively explored, especially for drug-target","Beyond property prediction, interaction prediction has been extensively explored, especially for drug-target",3.09,-26.9,0,0,1,11.96,9.96,-1.99,0,1,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,10,10,0
"Beyond property prediction, interaction prediction has been extensively explored, especially for drug-target","Beyond property prediction, interaction prediction has been extensively explored, especially for drug-target","or drug -disease interaction predictions. Many researchers e.g., NeurTN 17 have utilized drug-target","or drug -disease interaction predictions. Many researchers (e.g., NeurTN [17]) have utilized drug-target",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"or drug -disease interaction predictions. Many researchers e.g., NeurTN 17 have utilized drug-target","or drug -disease interaction predictions. Many researchers (e.g., NeurTN [17]) have utilized drug-target","interaction networks as input, where the nodes are drugs and targets and links are known drug-target relationship. These models typically infer new interactions based on the guilt-by-association principle and are",tionship. These models typically infer new interactions based on the guilt-by-association principle and are,4.92,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"interaction networks as input, where the nodes are drugs and targets and links are known drug-target relationship. These models typically infer new interactions based on the guilt-by-association principle and are",tionship. These models typically infer new interactions based on the guilt-by-association principle and are,"fundamentally different from the methods discussed in this work, which rely primarily on drugs’ structure","fundamentally different from the methods discussed in this work, which rely primarily on drugs’ structure",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"fundamentally different from the methods discussed in this work, which rely primarily on drugs’ structure","fundamentally different from the methods discussed in this work, which rely primarily on drugs’ structure","information represented as molecular graphs. Therefore, interaction network based approaches are excluded","information represented as molecular graphs. Therefore, interaction network based approaches are excluded",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"information represented as molecular graphs. Therefore, interaction network based approaches are excluded","information represented as molecular graphs. Therefore, interaction network based approaches are excluded",from further discussion in this section.,from further discussion in this section.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
from further discussion in this section.,from further discussion in this section.,"In drug discovery, one of the most critical and extensively studied relationships is the interaction between","In drug discovery, one of the most critical and extensively studied relationships is the interaction between",1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,10,10,0
"In drug discovery, one of the most critical and extensively studied relationships is the interaction between","In drug discovery, one of the most critical and extensively studied relationships is the interaction between","drugs or chemical compounds and their protein targets. In the literature, various terms are used to describe","drugs (or chemical compounds) and their protein targets. In the literature, various terms are used to describe",1,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"drugs or chemical compounds and their protein targets. In the literature, various terms are used to describe","drugs (or chemical compounds) and their protein targets. In the literature, various terms are used to describe","these interactions, each emphasizing different aspects. These include drug-target interaction, protein-ligand","these interactions, each emphasizing different aspects. These include drug-target interaction, protein-ligand",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"these interactions, each emphasizing different aspects. These include drug-target interaction, protein-ligand","these interactions, each emphasizing different aspects. These include drug-target interaction, protein-ligand","interaction, drug-target binding affinity, protein-ligand binding affinity, molecular docking. Computationally, given the 2D or 3D structures of two molecules, the interaction can be studied at three levels: 1 binary","ally, given the 2D or 3D structures of two molecules, the interaction can be studied at three levels: (1) binary",4.92,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"interaction, drug-target binding affinity, protein-ligand binding affinity, molecular docking. Computationally, given the 2D or 3D structures of two molecules, the interaction can be studied at three levels: 1 binary","ally, given the 2D or 3D structures of two molecules, the interaction can be studied at three levels: (1) binary","interaction  i.e., whether an interaction occurs, 2 binding affinity a numerical value, typically reflecting","interaction (i.e., whether an interaction occurs), (2) binding affinity (a numerical value, typically reflecting",1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"interaction  i.e., whether an interaction occurs, 2 binding affinity a numerical value, typically reflecting","interaction (i.e., whether an interaction occurs), (2) binding affinity (a numerical value, typically reflecting","binding free energy, and 3 docking or protein-ligand binding dynamics.","binding free energy), and (3) docking or protein-ligand binding dynamics.",1,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"binding free energy, and 3 docking or protein-ligand binding dynamics.","binding free energy), and (3) docking or protein-ligand binding dynamics.","GNN-based approaches have been proposed to predict drug-target interactions based on their 2D structure. For example, CGIB 28 predicted interactions primarily using substructure information from paired","ture. For example, CGIB [28] predicted interactions primarily using substructure information from paired",4.92,0,1,0,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,10,10,0
"GNN-based approaches have been proposed to predict drug-target interactions based on their 2D structure. For example, CGIB 28 predicted interactions primarily using substructure information from paired","ture. For example, CGIB [28] predicted interactions primarily using substructure information from paired","graphs. MGraphDTA 27 predicted drug–target binding affinities based on 2D compound graphs and protein sequences. It utilized a deep GNN to capture both local and global molecular structures and a multiscale convolutional neural network CNN to extract features from protein sequences. However, capturing","scale convolutional neural network (CNN) to extract features from protein sequences. However, capturing",8.84,0,1,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"graphs. MGraphDTA 27 predicted drug–target binding affinities based on 2D compound graphs and protein sequences. It utilized a deep GNN to capture both local and global molecular structures and a multiscale convolutional neural network CNN to extract features from protein sequences. However, capturing","scale convolutional neural network (CNN) to extract features from protein sequences. However, capturing",long-range dependencies within complex molecular graphs remains a challenge for such models. Given the,long-range dependencies within complex molecular graphs remains a challenge for such models. Given the,1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
long-range dependencies within complex molecular graphs remains a challenge for such models. Given the,long-range dependencies within complex molecular graphs remains a challenge for such models. Given the,"superior performance generally observed when utilizing 3D molecular geometries, the trend shows that more","superior performance generally observed when utilizing 3D molecular geometries, the trend shows that more",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"superior performance generally observed when utilizing 3D molecular geometries, the trend shows that more","superior performance generally observed when utilizing 3D molecular geometries, the trend shows that more","approaches incorporate 3D information for interaction prediction, especially for binding affinity prediction","approaches incorporate 3D information for interaction prediction, especially for binding affinity prediction",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"approaches incorporate 3D information for interaction prediction, especially for binding affinity prediction","approaches incorporate 3D information for interaction prediction, especially for binding affinity prediction",and docking.,and docking.,1,0,1,1,0,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
and docking.,and docking.,"For binding affinity prediction, the inputs are usually protein-ligand complexes, and the objective is to","For binding affinity prediction, the inputs are usually protein-ligand complexes, and the objective is to",1,14.94,0,0,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,1,0,0,0,0,1,0,0,0,1,10,10,0
"For binding affinity prediction, the inputs are usually protein-ligand complexes, and the objective is to","For binding affinity prediction, the inputs are usually protein-ligand complexes, and the objective is to","predict a binding score that reflects the strength of interaction, typically in terms of free energy. Recent","predict a binding score that reflects the strength of interaction, typically in terms of free energy. Recent",1,-14.94,0,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
"predict a binding score that reflects the strength of interaction, typically in terms of free energy. Recent","predict a binding score that reflects the strength of interaction, typically in terms of free energy. Recent","developments have leveraged 3D graph representation learning to tackle this problem. For instance, Jones","developments have leveraged 3D graph representation learning to tackle this problem. For instance, Jones",1,0,1,1,1,9.96,9.96,0,1,0,0,0,0,0,0,1,1,1,0,1,0,0,0,1,0,0,0,1,10,10,1
